Apollo Commercial Real Estate Finance Inc
For the period ended Jun 30, 2024. Filed Aug 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 6, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands—except share data)
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| Assets: | ||
| Cash and cash equivalents | $174,703 | $225,438 |
| Commercial mortgage loans, net(1)(3) | 7,909,125 | 7,925,359 |
| Subordinate loans, net(2)(3) | 384,777 | 432,734 |
| Real estate owned, held for investment, net(4) (net of $18,541 and $10,404 accumulated depreciation in 2024 and 2023, respectively) | 665,568 | 519,498 |
| Other assets | 90,467 | 85,623 |
| Derivative assets, net | 47,749 | 29,425 |
| Assets related to real estate owned, held for sale | — | 78,653 |
| Total Assets | $9,272,389 | $9,296,730 |
| Liabilities and Stockholders' Equity | ||
| Liabilities: | ||
| Secured debt arrangements, net | $5,628,925 | $5,538,476 |
| Senior secured term loans, net | 756,673 | 759,150 |
| Senior secured notes, net | 496,033 | 495,637 |
| Debt related to real estate owned, held for investment, net | 235,418 | 161,562 |
| Accounts payable, accrued expenses and other liabilities(5) | 149,113 | 120,334 |
| Payable to related party | 9,179 | 9,553 |
| Liabilities related to real estate owned, held for sale | — | 3,285 |
| Total Liabilities | 7,275,341 | 7,087,997 |
| Commitments and Contingencies (see Note 18) | ||
| Stockholders' Equity: | ||
| Preferred stock, $0.01 par value, 50,000,000 shares authorized, Series B-1, 6,770,393 shares issued and outstanding ($169,260 liquidation preference) in 2024 and 2023 (see Note 17) | 68 | 68 |
| Common stock, $0.01 par value, 450,000,000 shares authorized, 138,438,433 and 141,358,605 shares issued and outstanding in 2024 and 2023, respectively | 1,385 | 1,414 |
| Additional paid-in-capital | 2,690,660 | 2,727,488 |
| Accumulated deficit | (695,065) | (520,237) |
| Total Stockholders' Equity | 1,997,048 | 2,208,733 |
| Total Liabilities and Stockholders' Equity | $9,272,389 | $9,296,730 |
(1)
Includes $7,897,660 and$7,705,491 pledged as collateral under secured debt arrangements in 2024 and 2023, respectively.
(2)
Includes $232,991 pledged as collateral under secured debt arrangements in 2023.
(3)
Net of$377,819 and$219,482 CECL Allowances comprised of$342,500 and$193,000 Specific CECL Allowance and$35,319 and$26,482 General CECL Allowance in 2024 and 2023, respectively.
(4)
Includes$154,048 pledged as collateral under secured debt arrangements in 2023.
(5)
Includes$3,622 and$4,017 of General CECL Allowance related to unfunded commitments on commercial mortgage loans and subordinate loans, net in 2024 and 2023, respectively.
Condensed Consolidated Statement of Operations (Unaudited)
(in thousands—except share and per share data)
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Net interest income: | ||||
| Interest income from commercial mortgage loans | $179,388 | $174,124 | $363,104 | $340,271 |
| Interest income from subordinate loans and other lending assets | 842 | 5,110 | 1,691 | 14,817 |
| Interest expense | (128,472) | (116,278) | (256,359) | (221,146) |
| Net interest income | $51,758 | $62,956 | $108,436 | $133,942 |
| Revenue from real estate owned operations | 29,350 | 29,208 | 53,207 | 45,339 |
| Total net revenue | $81,108 | $92,164 | $161,643 | $179,281 |
| Operating expenses: | ||||
| General and administrative expenses (includes equity-based compensation of $4,157 and $8,345 in 2024 and $4,377 and $8,735 in 2023, respectively) | $(7,488) | $(7,471) | $(14,861) | $(14,486) |
| Management fees to related party | (9,173) | (9,390) | (18,594) | (18,907) |
| Operating expenses related to real estate owned | (21,767) | (19,961) | (41,660) | (33,967) |
| Depreciation and amortization on real estate owned | (2,287) | (2,202) | (6,943) | (6,188) |
| Total operating expenses | $(40,715) | $(39,024) | $(82,058) | $(73,548) |
| Other income, net | $641 | $2,340 | $1,211 | $3,072 |
| Increase in current expected credit loss allowance, net | (10,258) | (61,648) | (157,942) | (66,038) |
| Foreign currency translation gain (loss) | (1,362) | 21,557 | (20,925) | 40,191 |
| Gain (loss) on foreign currency forward contracts (includes unrealized gains (losses) of $911 and $18,964 in 2024 and ($20,102) and ($55,953) in 2023, respectively) | 6,377 | (17,116) | 29,775 | (31,251) |
| Gain (loss) on interest rate hedging instruments (includes unrealized gains (losses) of ($457) and ($651) in 2024 and ($4,328) and ($9,141) in 2023, respectively) | 94 | 55 | 450 | (52) |
| Reversal of valuation allowance, commercial mortgage loan held for sale | 679 | — | — | — |
| Net realized loss on investments | (679) | (81,980) | (679) | (86,604) |
| Gain on extinguishment of debt | — | 252 | — | 465 |
| Net income (loss) before taxes | $35,885 | $(83,400) | $(68,525) | $(34,484) |
| Income tax provision | (100) | — | (214) | — |
| Net income (loss) | $35,785 | $(83,400) | $(68,739) | $(34,484) |
| Preferred dividends | (3,068) | (3,068) | (6,136) | (6,136) |
| Net income (loss) available to common stockholders | $32,717 | $(86,468) | $(74,875) | $(40,620) |
| Net income (loss) per share of common stock: | ||||
| Basic | $0.23 | $(0.62) | $(0.54) | $(0.30) |
| Diluted | $0.23 | $(0.62) | $(0.54) | $(0.30) |
| Basic weighted-average shares of common stock outstanding | 140,438,676 | 141,341,238 | 141,154,140 | 141,207,597 |
| Diluted weighted-average shares of common stock outstanding | 140,611,532 | 141,341,238 | 141,154,140 | 141,207,597 |
| Dividend declared per share of common stock | $0.35 | $0.35 | $0.70 | $0.70 |
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)
(in thousands—except share and per share data)
| Preferred Stock · Common Stock · AdditionalPaid-In- · Accumulated | |||||||
|---|---|---|---|---|---|---|---|
| Shares | Par | Shares | Par | Capital | Deficit | Total | |
| Balance at January 1, 2024 | 6,770,393 | $68 | 141,358,605 | $1,414 | $2,727,488 | $(520,237) | $2,208,733 |
| Capital increase (decrease) related to Equity Incentive Plan | — | — | 738,110 | 7 | (3,093) | — | (3,086) |
| Net loss | — | — | — | — | — | (104,524) | (104,524) |
| Dividends declared on preferred stock - $0.45 per share | — | — | — | — | — | (3,068) | (3,068) |
| Dividends declared on common stock and RSUs - $0.35 per share | — | — | — | — | — | (50,620) | (50,620) |
| Balance at March 31, 2024 | 6,770,393 | $68 | 142,096,715 | $1,421 | $2,724,395 | $(678,449) | $2,047,435 |
| Capital increase related to Equity Incentive Plan | — | — | 65,490 | 1 | 4,147 | — | 4,148 |
| Repurchase of common stock | — | — | (3,723,772) | (37) | (37,882) | — | (37,919) |
| Net Income | — | — | — | — | — | 35,785 | 35,785 |
| Dividends declared on preferred stock - $0.45 per share | — | — | — | — | — | (3,068) | (3,068) |
| Dividends declared on common stock and RSUs - $0.35 per share | — | — | — | — | — | (49,333) | (49,333) |
| Balance at June 30, 2024 | 6,770,393 | $68 | 138,438,433 | $1,385 | $2,690,660 | $(695,065) | $1,997,048 |
| Preferred Stock · Common Stock · AdditionalPaid-In- · Accumulated | |||||||
|---|---|---|---|---|---|---|---|
| Shares | Par | Shares | Par | Capital | Deficit | Total | |
| Balance at January 1, 2023 | 6,770,393 | $68 | 140,595,995 | $1,406 | $2,716,907 | $(363,877) | $2,354,504 |
| Capital increase (decrease) related to Equity Incentive Plan | — | — | 670,044 | 7 | (2,352) | — | (2,345) |
| Net income | — | — | — | — | — | 48,916 | 48,916 |
| Dividends declared on preferred stock - $0.45 per share | — | — | — | — | — | (3,068) | (3,068) |
| Dividends declared on common stock and RSUs - $0.35 per share | — | — | — | — | — | (50,446) | (50,446) |
| Balance at March 31, 2023 | 6,770,393 | $68 | 141,266,039 | $1,413 | $2,714,555 | $(368,475) | $2,347,561 |
| Capital increase related to Equity Incentive Plan | — | — | 77,138 | — | 4,365 | — | 4,365 |
| Net loss | — | — | — | — | — | (83,400) | (83,400) |
| Dividends declared on preferred stock - $0.45 per share | — | — | — | — | — | (3,068) | (3,068) |
| Dividends declared on common stock and RSUs - $0.35 per share | — | — | — | — | — | (50,467) | (50,467) |
| Balance at June 30, 2023 | 6,770,393 | $68 | 141,343,177 | $1,413 | $2,718,920 | $(505,410) | $2,214,991 |
Condensed Consolidated Statement of Cash Flows (Unaudited)
(in thousands)
| Six Months Ended June 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net loss | $(68,739) | $(34,484) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Amortization of discount/premium and payment-in-kind interest | (13,465) | (16,764) |
| Amortization of deferred financing costs | 8,556 | 7,948 |
| Equity-based compensation | 8,345 | 8,735 |
| Increase in current expected credit loss allowance, net | 157,942 | 66,038 |
| Foreign currency loss (gain) | 21,405 | (24,264) |
| Unrealized loss (gain) on foreign currency contracts | (18,964) | 55,953 |
| Unrealized loss on interest rate hedging instruments | 651 | 9,141 |
| Depreciation and amortization on real estate owned | 6,943 | 6,188 |
| Gain on extinguishment of debt | — | (465) |
| Net realized loss on investment | 679 | 86,604 |
| Changes in operating assets and liabilities: | ||
| Proceeds received from payment-in-kind interest | — | 3,573 |
| Other assets | (1,500) | (7,163) |
| Payment for interest rate cap | (11) | — |
| Accounts payable, accrued expenses and other liabilities | 1,621 | (1,120) |
| Payable to related party | (374) | (338) |
| Net cash provided by operating activities | $103,089 | $159,582 |
| Cash flows from investing activities: | ||
| New funding of commercial mortgage loans | (495,280) | (181,017) |
| Add-on funding of commercial mortgage loans | (410,072) | (181,630) |
| Add-on funding of subordinate loans | (27,766) | (63,252) |
| Proceeds received from the repayment and sale of commercial mortgage loans | 752,773 | 607,762 |
| Proceeds received from the repayment of subordinate loans and other lending assets | 201 | 21,672 |
| Origination and exit fees received on commercial mortgage loans, and subordinate loans, net | 17,159 | 4,940 |
| Increase (decrease) in collateral related to derivative contracts, net | 25,790 | (69,560) |
| Capital expenditures on real estate assets | (78,340) | (29,433) |
| Cash received from hotel title assumption | — | 569 |
| Net cash provided by (used in) investing activities | $(215,535) | $110,051 |
| Cash flows from financing activities: | ||
| Proceeds from secured debt arrangements | 1,177,928 | 323,236 |
| Proceeds related to financing on real estate owned | 74,648 | — |
| Repayments of secured debt arrangements | (1,030,594) | (343,229) |
| Repayments of senior secured term loan principal | (4,000) | (4,000) |
| Repayments and repurchases of convertible notes | — | (43,472) |
| Payment of deferred financing costs | (5,872) | (6,896) |
| Payment of withholding tax on RSU delivery | (7,284) | (6,714) |
| Repurchase of common stock | (37,919) | — |
| Dividends on common stock | (101,459) | (101,089) |
| Dividends on preferred stock | (6,136) | (6,136) |
| Net cash provided by (used in) financing activities | $59,312 | $(188,300) |
Condensed Consolidated Statement of Cash Flows (Unaudited) (Continued)
(in thousands)
| Six Months Ended June 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Net increase (decrease) in cash and cash equivalents, including cash classified within assets related to real estate owned, held for sale | $(53,134) | $81,333 |
| Decrease in cash classified within assets related to real estate owned, held for sale | 577 | 2,705 |
| Net increase (decrease) in cash and cash equivalents | $(52,557) | $84,038 |
| Cash and cash equivalents beginning of period | 225,438 | 222,030 |
| Effects of foreign currency translation on cash and cash equivalents | 1,822 | 1,984 |
| Cash and cash equivalents end of period | $174,703 | $308,052 |
| Supplemental disclosure of cash flow information: | ||
| Interest paid | $252,484 | $207,604 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Dividend declared, not yet paid | $52,401 | $53,029 |
| Change in participation sold | — | (25,130) |
| Change in loan proceeds held by servicer | (837) | 52,577 |
| Assumption of real estate | — | 75,000 |
| Assumption of other assets related to real estate owned | — | 2,827 |
| Assumption of accounts payable, accrued expenses and other liabilities related to real estate owned | — | (3,396) |
| Transfer of assets to assets related to real estate owned, held for sale | — | 79,021 |
| Transfer of assets related to real estate owned, held for sale to assets related to real estate owned held for investment, net | 70,688 | 151,676 |
| Transfer of assets related to real estate owned, held for sale to other assets | 2,280 | 4,357 |
| Transfer of liabilities to liabilities related to real estate owned, held for sale | — | 1,438 |
| Transfer of liabilities related to real estate owned, held for sale to accounts payable, accrued expenses and other liabilities | 3,937 | 7,163 |
| Restructuring of commercial mortgage loan to subordinate loan | 74,304 | — |
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 – Organization
Apollo Commercial Real Estate Finance, Inc. (together with its consolidated subsidiaries, is referred to throughout this report as the "Company," "ARI," "we," "us" and "our") is a corporation that has elected to be taxed as a real estate investment trust ("REIT") for U.S. federal income tax purposes and primarily originates, acquires, invests in and manages performing commercial first mortgage loans, subordinate financings, and other commercial real estate related debt investments. These asset classes are referred to as our target assets.
We were formed in Maryland on June 29, 2009, commenced operations on September 29, 2009 and are externally managed and advised by ACREFI Management, LLC (the "Manager"), an indirect subsidiary of Apollo Global Management, Inc. (together with its subsidiaries, "Apollo").
We elected to be taxed as a REIT under the Internal Revenue Code of 1986, as amended, commencing with the taxable year ended December 31, 2009. To maintain our tax qualification as a REIT, we are required to distribute at least 90% of our taxable income, excluding net capital gains, to stockholders and meet certain other asset, income, and ownership tests.
Note 2 – Summary of Significant Accounting Policies
Basis of Presentation
The accompanying condensed consolidated financial statements include our accounts and those of our consolidated subsidiaries. All intercompany amounts have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Our most significant estimates include current expected credit loss ("CECL") allowances. Actual results may differ from estimates.
These unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission (the "SEC"). In the opinion of management, all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows have been included. Our results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the full year or any other future period.
We currently operate inone reporting segment.
Recent Accounting Pronouncements
In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07 "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07"). ASU 2023-07 intends to improve reportable segment disclosure requirements, enhance interim disclosure requirements and provide new segment disclosure requirements for entities with a single reportable segment. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods with fiscal years beginning after December 15, 2024. ASU 2023-07 is to be adopted retrospectively to all prior periods presented. We are currently assessing the impact this guidance will have on our consolidated financial statements; however, we do not expect a material impact.
In December 2023, the FASB issued ASU 2023-09 "Improvements to Income Tax Disclosures" ("ASU 2023-09"). ASU 2023-09 intends to improve the transparency of income tax disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 and is to be adopted on a prospective basis with the option to apply retrospectively. We are currently assessing the impact of this guidance; however, we do not expect a material impact to our consolidated financial statements.
Note 3 – Fair Value Disclosure
GAAP establishes a hierarchy of valuation techniques based on the observability of the inputs utilized in measuring financial instruments at fair value. Market-based or observable inputs are the preferred source of values, followed by valuation models using management's assumptions in the absence of market-based or observable inputs. The three levels of the hierarchy as noted in Accounting Standards Codification ("ASC") Topic 820, "Fair Value Measurements and Disclosures" ("ASC 820") are described below:
Level I — Quoted prices in active markets for identical assets or liabilities.
Level II — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.
Level III — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.
While we anticipate that our valuation methods are appropriate and consistent with valuation methods used by other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. We use inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.
The fair values of foreign exchange ("Fx") forwards are determined by comparing the contracted forward exchange rate to the current market exchange rate. The current market exchange rates are determined by using market spot rates, forward rates and interest rate curves for the underlying countries. Our Fx forwards are classified as Level II in the fair value hierarchy.
The fair values of our interest rate caps are determined by using the market standard methodology of discounting the future expected cash receipts that occur when variable interest rates rise above the strike rates of the interest rate caps. The variable interest rates used in the calculation of projected receipts on the interest rate caps are based on a third-party expert's expectation of future interest rates derived from observable market interest rate curves and volatility. Our interest rate caps are classified as Level II in the fair value hierarchy and manage our exposure to variable cash flows on certain of our borrowings. As of December 31, 2023, we heldone interest rate cap related to our construction financing which was purchased on September 26, 2023. As of June 30, 2024, we heldtwo interest rate caps, one related to financing on a full service luxury hotel in Washington D.C. ("D.C. Hotel") which was purchased on June 13, 2024, and one related to our construction financing. Refer to "Note 5 – Real Estate Owned" and "Note 11 – Derivatives" for further detail.
The following table summarizes the levels in the fair value hierarchy into which our assets and liabilities with recurring fair value measurements were categorized as of June 30, 2024 and December 31, 2023 ($ in thousands):
| Fair Value as of June 30, 2024 | Fair Value as of December 31, 2023 | |||||||
|---|---|---|---|---|---|---|---|---|
| Level I | Level II | Level III | Total | Level I | Level II | Level III | Total | |
| Recurring fair value measurements: | ||||||||
| Foreign currency forward, net | $— | $47,029 | $— | $47,029 | $— | $28,065 | $— | $28,065 |
| Interest rate cap assets | — | 720 | — | 720 | — | 1,360 | — | 1,360 |
| Total financial instruments | $— | $47,749 | $— | $47,749 | $— | $29,425 | $— | $29,425 |
Non-recurring Fair Value Measurements
Loans Held for Sale
Loans are classified as held for sale if there is an intent to sell them in the short-term following the reporting date. These loans are recorded at the lower of amortized cost or fair value, less selling costs, unless the fair value option was elected at the time of origination. If the loan's fair value, less selling costs, is determined to be less than its amortized cost, a nonrecurring fair value adjustment may be recorded through a valuation allowance.
The fair value of loans held for sale may be estimated using sales of comparable loans as supported by independent market data, or a contractually negotiated sales price. We consider the inputs used to calculate the fair value of loans held for sale as unobservable inputs. Accordingly, we classify the fair value of loans held for sale within Level III of the fair value hierarchy.
During the three months ended June 30, 2024, we sold a commercial mortgage loan collateralized by a hotel property located in Honolulu, HI. The loan was previously classified as held for sale and was sold at a price of 99.5%. We recorded a realized loss of $0.7 million within realized loss on investments on our condensed consolidated statement of operations for thethree and six months ended June 30, 2024. There wereno loans classified as held for sale as of June 30, 2024.
Real Estate Owned
Property acquired through foreclosure or deed-in-lieu of foreclosure is classified as real estate owned and recognized at fair value on our condensed consolidated balance sheet upon acquisition in accordance with ASC Topic 805, "Business Combinations" ("ASC 805"). We are required to record real estate owned, a nonfinancial asset, at fair value on a non-recurring basis in accordance with ASC 820. Under ASC 820, we may utilize the income, market or cost approach (or combination thereof) to determine the fair value of real estate owned. We deem the inputs used in these approaches to be significant unobservable inputs. Therefore, we classify the fair value of real estate owned within Level III of the fair value hierarchy.
On March 31, 2023, we acquired legal title of a hotel property in Atlanta, GA ("Atlanta Hotel") through a deed-in-lieu of foreclosure. At the time of acquisition, we determined the fair value of the net real estate assets to be $75.0 million, using a combination of market and income approaches. We utilized a discount rate and capitalization rate of 10.5% and 9.5%, respectively. During the three months ended June 30, 2023, the Atlanta Hotel's assets and liabilities were reclassified to held for sale and the fair value of the net real estate assets, less costs to sell, was in excess of our cost basis. During the three months ended March 31, 2024, we determined that the sale to a third party from whom we received an unsolicited offer was no longer probable, and we are not actively marketing the property for sale. Therefore, as of March 31, 2024, the Atlanta Hotel no longer met the criteria for held for sale and was reclassified to real estate owned, held for investment. No impairments had been recorded as of June 30, 2024 or December 31, 2023.
On August 3, 2022, we acquired legal title of a multifamily development property located in downtown Brooklyn, NY ("Brooklyn Development") through a deed-in-lieu of foreclosure. We determined the fair value of the real estate assumed to be $270.1 million, based on the market value of the land at the time of acquisition. No impairments had been recorded as of June 30, 2024 or December 31, 2023.
On May 24, 2021, we acquired legal title to the D.C. Hotel through a deed-in-lieu of foreclosure. We assumed the D.C. Hotel's assets and liabilities, including a $110.0 million mortgage loan which we repaid at par. At the time of acquisition, we determined the fair value of the real estate assets to be $154.3 million. No impairments had been recorded as of June 30, 2024 or December 31, 2023.
Refer to "Note 5 – Real Estate Owned" for additional discussions.
Note 4 – Commercial Mortgage Loans, Subordinate Loans and Other Lending Assets, Net
Our loan portfolio was comprised of the following at June 30, 2024 and December 31, 2023 ($ in thousands):
| Loan Type | June 30, 2024 | December 31, 2023 |
|---|---|---|
| Commercial mortgage loans, net(1) | $7,909,125 | $7,925,359 |
| Subordinate loans, net | 384,777 | 432,734 |
| Carrying value, net | $8,293,902 | $8,358,093 |
(1)
Includes$8.3 million and$95.5 million in 2024 and 2023, respectively, of contiguous financing structured as subordinate loans.
Our loan portfolio consisted of 96% and 99% floating rate loans, based on amortized cost, as of June 30, 2024 and December 31, 2023, respectively.
Activity relating to our loan portfolio for thesix months ended June 30, 2024 was as follows ($ in thousands):
| PrincipalBalance · Deferred Fees/Other Items · Specific CECL Allowance · Carrying Value, Net | |||||
|---|---|---|---|---|---|
| December 31, 2023 | $8,610,110 | $(32,535) | $(193,000) | $8,384,575 | |
| New loan fundings | 495,280 | — | — | 495,280 | |
| Add-on loan fundings(1) | 437,838 | — | — | 437,838 | |
| Loan repayments and sale | (758,889) | — | — | (758,889) | |
| Gain (loss) on foreign currency translation | (76,324) | 221 | — | (76,103) | |
| Increase in Specific CECL Allowance, net | — | — | (149,500) | (149,500) | |
| Realized loss on investment | (679) | — | — | (679) | |
| Deferred fees and other items(2) | — | (18,540) | — | (18,540) | |
| Amortization of fees | — | 15,239 | — | 15,239 | |
| June 30, 2024 | $8,707,336 | $(35,615) | $(342,500) | $8,329,221 | |
| General CECL Allowance(3) | (35,319) | ||||
| Carrying value, net | $8,293,902 | ||||
(1)
Represents fundings subsequent to loan closing.
(2)
Other items primarily consist of purchase discounts or premiums, cost recovery interest, exit fees, and deferred origination expenses.
(3)
$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.
The following table details overall statistics for our loan portfolio at the dates indicated ($ in thousands):
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| Number of loans | 50 | 50 |
| Principal balance | $8,707,336 | $8,610,110 |
| Carrying value, net | $8,293,902 | $8,358,093 |
| Unfunded loan commitments(1) | $436,628 | $868,582 |
| Weighted-average cash coupon(2) | 8.3% | 8.3% |
| Weighted-average remaining fully-extended term(3) | 2.3 years | 2.3 years |
| Weighted-average expected term(4) | 1.9 years | 1.8 years |
(1)
Unfunded loan commitments are funded to finance construction costs, tenant improvements, leasing commissions, or carrying costs. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date.
(2)
For floating rate loans, based on applicable benchmark rates as of the specified dates. For loans placed on non-accrual, the interest rate used in calculating weighted-average cash coupon is 0%.
(3)
Assumes all extension options are exercised.
(4)
Expected term represents our estimated timing of repayments as of the specified dates. Excludes risk-rated five loans.
Property Type
The table below details the property type of the properties securing the loans in our portfolio at the dates indicated ($ in thousands):
| June 30, 2024 | December 31, 2023 | |||
|---|---|---|---|---|
| Property Type | Carrying Value | % of Portfolio(1) | Carrying Value | % of Portfolio(1) |
| Hotel | $2,001,033 | 24.0% | $2,128,256 | 25.4% |
| Office | 1,692,661 | 20.3 | 1,593,320 | 19.0 |
| Retail | 1,399,957 | 16.8 | 1,407,764 | 16.8 |
| Residential | 1,205,817 | 14.5 | 1,247,238 | 14.9 |
| Mixed Use | 512,937 | 6.2 | 679,303 | 8.1 |
| Healthcare | 500,563 | 6.0 | 511,803 | 6.1 |
| Industrial | 278,404 | 3.3 | 293,133 | 3.5 |
| Other(2) | 737,849 | 8.9 | 523,758 | 6.2 |
| Total | $8,329,221 | 100.0% | $8,384,575 | 100.0% |
| General CECL Allowance(3) | (35,319) | (26,482) | ||
| Carrying value, net | $8,293,902 | $8,358,093 | ||
(1)
Percentage of portfolio calculations are made prior to consideration of General CECL Allowance.
(2)
Other property types include pubs (2.6%), caravan parks (2.4%), parking garages (2.3%) and urban predevelopment (1.6%) in 2024, and caravan parks (2.4%), parking garages (2.3%) and urban predevelopment (1.5%) in 2023.
(3)
$3.6 million and$4.0 million of the General CECL Allowance for 2024 and 2023, respectively, is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheets.
Geography
The table below details the geographic distribution of the properties securing the loans in our portfolio at the dates indicated ($ in thousands):
| June 30, 2024 | December 31, 2023 | |||
|---|---|---|---|---|
| Geographic Location | Carrying Value | % of Portfolio(1) | Carrying Value | % of Portfolio(1) |
| United Kingdom | $2,818,068 | 33.8% | $2,675,097 | 31.9% |
| New York City | 1,597,363 | 19.2 | 1,736,856 | 20.7 |
| Other Europe(2) | 1,432,136 | 17.2 | 1,686,425 | 20.1 |
| Southeast | 663,096 | 8.0 | 535,054 | 6.4 |
| Midwest | 506,226 | 6.1 | 522,137 | 6.2 |
| West | 509,774 | 6.1 | 484,842 | 5.8 |
| Other(3) | 802,558 | 9.6 | 744,164 | 8.9 |
| Total | $8,329,221 | 100.0% | $8,384,575 | 100.0% |
| General CECL Allowance(4) | (35,319) | (26,482) | ||
| Carrying value, net | $8,293,902 | $8,358,093 | ||
(1)
Percentage of portfolio calculations are made prior to consideration of General CECL Allowance.
(2)
Other Europe includes Germany (7.2%), Italy (3.3%), Spain (3.2%), Sweden (2.8%), Ireland (0.5%) and the Netherlands (0.2%) in 2024 and Germany (7.4%), Italy (4.9%), Spain (4.2%), Sweden (2.9%), Ireland (0.5%) and the Netherlands (0.2%) in 2023.
(3)
Other includes Northeast (4.6%), Mid-Atlantic (2.2%), Southwest (1.7%) and Other (1.1%) in 2024 and Northeast (5.0%), Mid-Atlantic (1.1%), Southwest (1.7%) and Other (1.1%) in 2023.
(4)
$3.6 million and$4.0 million of the General CECL Allowance for 2024 and 2023, respectively, is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheets.
Risk Rating
We assess the risk factors of each loan and assign a risk rating based on a variety of factors, including, without limitation, loan to value ("LTV") ratio, debt yield, property type, geographic and local market dynamics, physical condition, cash flow volatility, leasing and tenant profile, loan structure and exit plan, and project sponsorship. We apply these various factors on a case-by-case basis depending on the facts and circumstances for each loan, and the different factors may be given different weightings in different situations. This review is performed quarterly. Based on a 5-point scale, our loans are rated "1" through "5," from less risk to greater risk, which ratings are defined as follows:
Very low risk
Low risk
Moderate/average risk
High risk/potential for loss: a loan that has a risk of realizing a principal loss
Impaired/loss likely: a loan that has a high risk of realizing principal loss, has incurred principal loss, or an impairment has been recorded
The following tables present the carrying value of our loan portfolio by year of origination and internal risk rating and gross write-offs by year of origination as of June 30, 2024 and December 31, 2023, respectively ($ in thousands):
| June 30, 2024 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amortized Cost(1) by Year Originated | ||||||||||||||||
| Risk Rating · Number of Loans · Total · % of Portfolio · 2024 · 2023 · 2022 · 2021 · 2020 · Prior | ||||||||||||||||
| 1 | — | $— | — % | $— | $— | $— | $— | $— | $— | |||||||
| 2 | 4 | 479,843 | 5.8% | — | — | 390,038 | 24,471 | — | 65,334 | |||||||
| 3 | 41 | 7,302,939 | 87.7% | 490,664 | 639,886 | 1,849,832 | 2,199,747 | 394,094 | 1,728,716 | |||||||
| 4 | 2 | 420,049 | 5.0% | — | — | 341,937 | — | — | 78,112 | |||||||
| 5 | 3 | 126,390 | 1.5% | — | — | — | — | 27,881 | 98,509 | |||||||
| Total | 50 | $8,329,221 | 100.0% | $490,664 | $639,886 | $2,581,807 | $2,224,218 | $421,975 | $1,970,671 | |||||||
| General CECL Allowance(2) | (35,319) | |||||||||||||||
| Total carrying value, net | $8,293,902 | |||||||||||||||
| Weighted-Average Risk Rating | 3.0 | |||||||||||||||
| Gross write-offs | $— | $— | $— | $— | $— | $— | $— | |||||||||
| December 31, 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Amortized Cost(1) by Year Originated | |||||||||||
| Risk Rating · Number of Loans · Total · % of Portfolio · 2023 · 2022 · 2021 · 2020 · 2019 · Prior | |||||||||||
| 1 | — | $— | —% | $— | $— | $— | $— | $— | $— | ||
| 2 | 4 | 478,440 | 5.7% | — | 280,572 | — | — | 132,309 | 65,560 | ||
| 3 | 42 | 7,548,252 | 90.0% | 440,720 | 2,426,511 | 2,285,902 | 387,323 | 1,465,618 | 542,177 | ||
| 4 | 2 | 88,112 | 1.1% | — | — | — | — | — | 88,112 | ||
| 5 | 2 | 269,771 | 3.2% | — | — | — | 169,881 | — | 99,890 | ||
| Total | 50 | $8,384,575 | 100.0% | $440,720 | $2,707,083 | $2,285,902 | $557,204 | $1,597,927 | $795,739 | ||
| General CECL Allowance(2) | (26,482) | ||||||||||
| Total carrying value, net | $8,358,093 | ||||||||||
| Weighted-Average Risk Rating | 3.0 | ||||||||||
| Gross write-offs | $81,890 | $— | $— | $— | $— | $— | $81,890 | ||||
(1)
Net of Specific CECL Allowance.
(2)
$3.6 million and$4.0 million of the General CECL Allowance for 2024 and 2023, respectively, is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheets.
CECL
In accordance with ASC Topic 326 "Financial Instruments – Credit Losses" ("ASC 326"), which we refer to as the "CECL Standard," we record allowances for loans and held-to-maturity debt securities that are deducted from the carrying amount of the assets to present the net carrying value of the amounts expected to be collected on the assets. We record loan specific allowances as a practical expedient under the CECL Standard ("Specific CECL Allowance"), which we apply to assets that are collateral dependent and where the borrower or sponsor is experiencing financial difficulty. For the remainder of the portfolio, we record a general allowance ("General CECL Allowance," and together with the Specific CECL Allowance, "CECL Allowances") on a collective basis by assets with similar risk characteristics. We have elected to use the weighted-average remaining maturity ("WARM") method in determining a General CECL Allowance for a majority of our portfolio. In the future, we may use other acceptable methods, such as a probability-of-default/loss-given-default method.
The following schedule illustrates changes in CECL Allowances for thesix months ended June 30, 2024 ($ in thousands):
| Specific CECL · General CECL Allowance · Total CECL · CECL Allowance as % of Amortized Cost | |||||||
|---|---|---|---|---|---|---|---|
| Allowance(1) | Funded | Unfunded | Total | Allowance | General(1) | Total | |
| December 31, 2023 | $193,000 | $26,482 | $4,017 | $30,499 | $223,499 | 0.38% | 2.61% |
| Changes: | |||||||
| Allowances (Reversals), net(2) | 142,000 | 6,076 | (392) | 5,684 | 147,684 | ||
| March 31, 2024 | $335,000 | $32,558 | $3,625 | $36,183 | $371,183 | 0.44% | 4.29% |
| Changes: | |||||||
| Allowances (Reversals), net(3) | 7,500 | 2,761 | (3) | 2,758 | 10,258 | ||
| June 30, 2024 | $342,500 | $35,319 | $3,622 | $38,941 | $381,441 | 0.47% | 4.40% |
(1)
Loans evaluated for Specific CECL Allowance are excluded from General CECL Allowance pool.
(2)
During the three months ended March 31, 2024, our General CECL Allowance increased by $5.7 million. The increase was primarily related to extending our expected loan repayment dates as well as an increase to the historical loss rate derived from Trepp's data. The increase was partially offset by the favorable impacts of portfolio seasoning. Additionally, during the three months ended March 31, 2024, we recorded an increase of $142.0 million to our Specific CECL Allowance. The increase was related to a mezzanine loan secured by the ultra-luxury residential property. Refer to discussion below.
(3)
During the three months ended June 30, 2024, our General CECL Allowance increased by $2.8 million primarily due to new loan originations as well as a more adverse outlook on our office portfolio. The increase was partially offset by the favorable impacts of portfolio seasoning. Additionally, during the three months ended June 30, 2024, we recorded an increase of $7.5 million to our Specific CECL Allowance. The increase was related to a mezzanine loan secured by an office building in Troy, MI. Refer to discussion below.
The following schedule illustrates changes in CECL Allowances for the six months ended June 30, 2023 ($ in thousands):
| Specific CECL · General CECL Allowance · Total CECL · CECL Allowance as % of Amortized Cost | |||||||
|---|---|---|---|---|---|---|---|
| Allowance(1) | Funded | Unfunded | Total | Allowance | General(1) | Total | |
| December 31, 2022 | $133,500 | $26,224 | $4,347 | $30,571 | $164,071 | 0.36% | 1.86% |
| Changes: | |||||||
| Allowances(2) | — | 4,043 | 348 | 4,391 | 4,391 | ||
| March 31, 2023 | $133,500 | $30,267 | $4,695 | $34,962 | $168,462 | 0.42% | 1.95% |
| Changes: | |||||||
| Allowances(3) | 141,480 | 2,009 | 139 | 2,148 | 143,628 | ||
| Write-offs(4) | (81,980) | — | — | — | (81,980) | ||
| June 30, 2023 | $193,000 | $32,276 | $4,834 | $37,110 | $230,110 | 0.46% | 2.70% |
(1)
Loans evaluated for Specific CECL Allowance are excluded from General CECL Allowance pool.
(2)
During the three months ended March 31, 2023, our General CECL Allowance increased by $4.4 million primarily due to an increase in our view of the remaining expected term of our loan portfolio. This increase was partially offset by the impact of portfolio seasoning and loan repayments and sales.
(3)
During the three months ended June 30, 2023, our General CECL Allowance increased by $2.1 million primarily due to a more adverse macroeconomic outlook and an increase in our view of the remaining expected term of certain of our loans. This increase was partially offset by the impact of portfolio seasoning. Additionally, during the three months ended June 30, 2023, we recorded an increase of $141.5 million to our Specific CECL Allowance. The increase was related to two mezzanine loans secured by the same ultra-luxury property. Refer to discussion below.
(4)
As of June 30, 2023, $82.0 million related to the most junior mezzanine loan secured by the ultra-luxury residential property was deemed unrecoverable. Accordingly, $82.0 million of previously recorded Specific CECL was written-off and recorded as a realized loss within net realized loss on investments in our June 30, 2023 condensed consolidated statement of operations. Refer to "Specific CECL Allowance" section below for further detail.
General CECL Allowance
In determining the General CECL Allowance using the WARM method, an annual historical loss rate, adjusted for macroeconomic estimates, is applied to the amortized cost of an asset, or pool of assets, over each subsequent period for the assets' remaining expected life. We considered various factors including (i) historical loss experience in the commercial real estate lending market, (ii) timing of expected repayments and satisfactions, (iii) expected future funding, (iv) capital subordinate to us when we are the senior lender, (v) capital senior to us when we are the subordinate lender, and (vi) our current and future view of the macroeconomic environment for a reasonable and supportable forecast period. The CECL Standard requires the use of significant judgment to arrive at an estimated credit loss. There is significant uncertainty related to future macroeconomic conditions, including inflation, labor shortages and interest rates.
We derive an annual historical loss rate based on a commercial mortgage-backed securities ("CMBS") database with historical losses from 1998 through the second quarter of 2024 provided by a third party, Trepp LLC ("Trepp"). We apply various filters to arrive at a CMBS dataset most analogous to our current portfolio from which to determine an appropriate historical loss rate. The annual historical loss rate is further adjusted to reflect our expectations of the macroeconomic environment for a reasonable and supportable forecast period of eight quarters. In assessing the macroeconomic environment, we consider macroeconomic factors, including unemployment rate, commercial real estate prices, and market liquidity. We compare the historical data for each metric to historical commercial real estate losses in order to determine the correlation of the data. We use projections, obtained from third-party service providers, of each factor to approximate the impact the macroeconomic outlook may have on our loss rate.
The General CECL Allowance on subordinate loans is calculated by incorporating both the loan balance of the position(s) of the structurally senior third-party lender(s) and the balance of our subordinate loan(s). The subordinate loans, by virtue of being the first loss position, are required to absorb losses prior to the senior position(s) being impacted, resulting in a higher percentage allowance attributable to the subordinate loan. The General CECL Allowance on unfunded loan commitments is time-weighted based on our expected commitment to fund such obligations. The General CECL Allowance on unfunded commitments is recorded as a liability on our condensed consolidated balance sheets within accounts payable, accrued expenses and other liabilities.
Additionally, we have made an accounting policy election to exclude accrued interest from the amortized cost basis of the related commercial mortgage loans and subordinate loans and other lending assets in determining the General CECL Allowance, as any uncollectible accrued interest receivable is written off in a timely manner. As of June 30, 2024 and December 31, 2023, accrued interest receivable was$75.0 million and$72.4 million, respectively, and included within other assets on our condensed consolidated balance sheets.
Although our secured debt obligations and senior secured term loan financing have a minimum tangible net worth maintenance covenant, the General CECL Allowance has no impact on these covenants as we are permitted to add back the General CECL Allowance for the computation of tangible net worth as defined in the respective agreements.
The following schedule sets forth our General CECL Allowance as of June 30, 2024 and December 31, 2023 ($ in thousands):
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| Commercial mortgage loans, net | $34,234 | $25,723 |
| Subordinate loans, net | 1,085 | 759 |
| Unfunded commitments(1) | 3,622 | 4,017 |
| Total General CECL Allowance | $38,941 | $30,499 |
(1)
The General CECL Allowance on unfunded commitments is recorded as a liability on our condensed consolidated balance sheets within accounts payable, accrued expenses and other liabilities.
Specific CECL Allowance
For collateral-dependent loans where we have deemed the borrower/sponsor to be experiencing financial difficulty and a more than moderate/average risk of realizing a principal loss, we have elected to apply a practical expedient in accordance with the CECL Standard in which the fair value of the underlying collateral is compared to the amortized cost of the loan in determining a Specific CECL Allowance. The Specific CECL Allowance is determined as the difference between the fair value of the underlying collateral and the carrying value of the loan (prior to the Specific CECL Allowance). When the repayment or satisfaction of a loan is dependent on a sale, rather than operations, of the collateral, the fair value is adjusted for the estimated cost to sell the collateral. Collateral-dependent loans evaluated for a Specific CECL Allowance are removed from the General CECL Allowance pool. The fair value of the underlying collateral is determined by using method(s) such as discounted cash flow, the market approach, or direct capitalization approach. The key unobservable inputs used to determine the fair value of the underlying collateral may vary depending on the information available to us and market conditions as of the valuation date.
We regularly evaluate the extent and impact of any credit migration associated with the performance and/or value of the underlying collateral property as well as the financial and operating capability of the borrower/sponsor on a loan-by-loan basis. The Specific CECL Allowance is evaluated on a quarterly basis. Specifically, a property's operating results and any cash reserves are analyzed and used to assess (i) whether cash from operations is sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and/or (iii) the liquidation value of the underlying collateral. We also evaluate the financial wherewithal of any loan guarantors as well as the borrower's competency in managing and operating the properties. In addition, we consider the overall economic environment, real estate sector and geographic sub-market in which the borrower operates. Such impairment analysis is completed and reviewed by asset management and finance personnel who utilize various data sources, including (i) periodic financial data such as debt service coverage ratio, property occupancy, tenant profile, rental rates, operating expenses, the borrower's exit plan, and capitalization and discount rates, (ii) site inspections and (iii) current credit spreads and discussions with market participants.
The following table summarizes our risk rated five loans as of June 30, 2024, which were analyzed for Specific CECL Allowances ($ in thousands):
| Type · Property type · Location · Amortized cost prior to Specific CECL Allowance · Specific CECL Allowance · Amortized cost · Interest recognition status/ as of date · Risk Rating | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mortgage | Retail(1)(2) | Cincinnati, OH | $165,509 | $67,000 | $98,509 | Non-Accrual/ 10/1/2019 | 5 | |||
| Mezzanine | Residential(3) | Manhattan, NY | 295,881 | 268,000 | 27,881 | Non-Accrual/ 7/1/2021 | 5 | |||
| Mezzanine | Office(4) | Troy, MI | 7,500 | 7,500 | - | Non-Accrual/ 6/30/2024 | 5 | |||
| Total | $468,890 | $342,500 | $126,390 | |||||||
(1)
The fair value of retail collateral was determined by applying a capitalization rate of 9.0%.
(2)
In September 2018, we entered a joint venture with Turner Consulting II, LLC ("Turner Consulting"), through an entity which owns the underlying property that secures our loan. Turner Consulting contributed 10% of the venture's equity and we contributed 90%. The entity was deemed to be a variable interest entity ("VIE"), and we determined that we are not the primary beneficiary of that VIE as we do not have the power to direct the entity's activities. During the second quarter of 2024, the loan's maturity was extended from September 2024 to September 2025.
(3)
The fair value of the residential collateral was determined by making certain projections and assumptions with respect to future performance and a discount rate of 10%.
(4)
The fair value of the office collateral was determined by applying an exit capitalization rate of 10% and a discount rate of 20%
For the six months ended June 30, 2024, we recorded an increase in our Specific CECL Allowance of $149.5 million, related to two of our subordinate loans. During the three months ended June 30, 2024, we recorded a Specific CECL Allowance of $7.5 million on a subordinate loan secured by our interest in a Class A office building in Troy, MI, which was attributable to low occupancy and limited leasing activity in the property's submarket. The loan's risk rating was downgraded from a four to a five and the loan was moved to non-accrual status as of June 30, 2024. As of June 30, 2024, the borrower was compliant with all contractual debt service payments. As discussed further below, we recorded an additional $142.0 million Specific CECL Allowance on our Junior Mezzanine A Loan (as defined below), during the three months ended March 31, 2024.
We cease accruing interest on loans if we deem the interest to be uncollectible with any previously accrued uncollected interest on the loan charged to interest income in the same period. The amortized cost basis, net of Specific CECL Allowance, for loans on non-accrual was$461.5 million and$693.7 million as of June 30, 2024 and December 31, 2023, respectively. Under certain circumstances, we may apply the cost recovery method under which interest collected on a loan reduces the loan's amortized cost. For the three and six months ended June 30, 2024, we received$0.8 million and$1.4 million, respectively, in interest that reduced amortized cost under the cost recovery method compared to$0.7 million and$1.3 million for the three and six months ended June 30, 2023, respectively.
As of June 30, 2024 and December 31, 2023, the amortized cost basis, net of Specific CECL Allowance, for loans with accrued interest past due 90 or more days was$461.5 million and$693.7 million, respectively. As of June 30, 2024 and December 31, 2023, there were no loans with accrued interest between 30 and 89 days past due.
Loan Modifications Pursuant to ASC 326
During the twelve months ended June 30, 2024, we provided the following loan modifications that require disclosure pursuant to ASC 326.
Cleveland Multifamily
In May 2021, we originated a first mortgage loan secured by a multifamily property in Cleveland, OH. In April 2024, we modified our loan to convert from a floating rate of Secured Overnight Financing Rate ("SOFR") +3.25% to a 6.0% fixed rate, and to provide atwo year term extension. These modified terms are included in the determination of our general CECL reserve for the quarter ended June 30, 2024. The loan is performing pursuant to its modified contractual terms and its risk rating remains a three as of June 30, 2024.
Manhattan Office
In March 2022, we originated a first mortgage loan secured by an office property in Manhattan, NY. In April 2024, we modified our loan to convert from a floating rate of SOFR +3.92% to a 5.0% fixed rate. This modified term is included in the determination of our general CECL reserve for the quarter ended June 30, 2024. The loan is performing pursuant to its modified contractual terms and its risk rating remains a three as of June 30, 2024.
Chicago Office
In March 2018, we originated a first mortgage loan secured by an office property in Chicago, IL. In July 2023, we modified our loan to provide atwo year term extension (and asix-month extension option) in exchange for a partial repayment. These modified terms are included in the determination of our general CECL reserve for the quarter ended June 30, 2024. The loan is performing pursuant to its contractual terms and its risk rating remains a four as of June 30, 2024.
Manhattan Residential
In August 2022, we refinanced three of our mezzanine loans (a senior mezzanine loan ("Senior Mezzanine Loan") and two junior mezzanine loans ("Junior Mezzanine A Loan" and "Junior Mezzanine B Loan" collectively referred to as "Junior Mezzanine Loan")), and originated a commercial mortgage loan ("Senior Loan") as part of an overall recapitalization. All of the loans are secured by an ultra-luxury residential property in Manhattan, NY.
In refinancing the Senior Mezzanine Loan and Junior Mezzanine Loan, we modified the loan terms with the borrower to include an interest rate reduction and two year extension of the term on all three loans. Based on our analysis under ASC Topic 310-20 "Receivables – Nonrefundable Fees and Other Costs" ("ASC 310-20"), we have deemed this refinance to be a continuation of our existing loans.
During 2022, sales velocity on the underlying property lagged behind the borrower's business plan and management's expectations. Based on this information and broader uncertainty across the ultra-luxury residential property market, we recorded a total loan Specific CECL Allowance of $66.5 million on the Junior Mezzanine B Loan and downgraded its risk rating to a five.
As property sales continued to trail behind the borrower's business plan during the first half of 2023, we ceased accruing interest on the Senior Loan and the Senior Mezzanine Loan as of May 1, 2023. During the second quarter of 2023, we deemed the $82.0 million Junior Mezzanine B Loan to be unrecoverable and therefore wrote off our mezzanine loan and recorded a realized loss of $82.0 million within net realized loss on investments in our condensed consolidated statement of operations. We also recorded a $126.0 million Specific CECL Allowance on the Junior Mezzanine A Loan and downgraded its risk rating to a five.
During the three months ended March 31, 2024, we recorded an additional $142.0 million Specific CECL Allowance on our Junior Mezzanine A Loan. The additional Specific CECL Allowance was primarily attributable to a reduction in list pricing of remaining units and slower sales pace at the property. The slower sales velocity coincided with the continued overall softening in the midtown Manhattan ultra-luxury submarket. Any future change to the Specific CECL Allowance will be based upon a number of factors, including but not limited to the continued assessment of both the potential nominal value of remaining inventory as well as the expected sales velocity.
During the three months ended June 30, 2024, our Senior Loan was refinanced by a third party lender, which resulted in a repayment of $108.3 million. The remaining Senior Loan balance was restructured into a subordinate loan ("Senior Mezzanine A Loan"), and extended by fourteen months to November 2025. Concurrently, the maturities of the Senior Mezzanine Loan and the Junior Mezzanine A Loan were extended to November 2025. All three loans remain on non-accrual status subsequent to the refinancing. Based on our analysis under ASC 310-20, we have deemed this refinance to be a continuation of our existing loans.
The modified loan terms as discussed above have been reflected in our calculation of CECL for the three months ended June 30, 2024. Refer to the "CECL" section above for additional information regarding our calculation of CECL Allowances.
As of June 30, 2024 and December 31, 2023, the aggregate amortized cost basis of these modified receivables was$441.1 million and$674.5 million, respectively, or 5.3% and 8.0% of our aggregate commercial mortgage loans and subordinate loans by amortized cost, respectively. There were no unfunded commitments as of both June 30, 2024 and December 31, 2023 related to these loans.
Other Loan Activity
We recognized$0.7 million and$0.8 million accelerated fees for the three and six months ended June 30, 2024 and$0.2 million for both the three and six months ended June 30, 2023.
During the three and six months ended June 30, 2023, we recorded$1.3 million and$2.5 million, respectively, of interest income related to a subordinate risk retention interest in a securitization vehicle. The subordinate risk retention interest was repaid in full during the third quarter of 2023.
During the three months ended March 31, 2023, we received £72.2 million ($88.4 million assuming conversion into U.S. Dollars ("USD")) full repayment of one of our commercial mortgage loans secured by an office property in London, UK, including all default interest accrued to date, which was approximately $0.7 million. In conjunction with the repayment, the related participation interest sold was also fully satisfied. Refer to "Note 12 – Participations Sold" for additional detail.
Loan Sales
From time to time, we may enter into sale transactions with other parties. All sale transactions are evaluated in accordance with ASC Topic 860, "Transfers and Servicing" ("ASC 860").
During the three months ended June 30, 2024, we sold a commercial mortgage loan collateralized by a hotel property located in Honolulu, HI. The loan was previously classified as held for sale and was sold at a price of 99.5%. Upon selling the commercial mortgage loan, we reversed the previously recorded valuation allowance and recorded a realized loss of $0.7 million included within realized loss on investments on our condensed consolidated statement of operations for thethree and six months ended June 30, 2024.
During the first quarter of 2023, we sold our entire interests inthree commercial mortgage loans secured by various properties in Europe, with aggregate commitments of €205.7 million ($219.0 million assuming conversion into USD, of which €115.0 million or $122.4 million assuming conversion into USD, was funded at the time of sale). Additionally, we sold a partial interest of £15.0 million ($18.2 million assuming conversion into USD) in a commercial mortgage loan secured by a mixed-use property located in London, United Kingdom. These sales were made to entities managed by affiliates of the Manager. We evaluated the transaction under ASC 860 and determined the sale of our entire interests and the sale of the partial interest met the criteria for sale accounting. In connection with these sales, we recorded a net gain of approximately $0.2 million within net realized loss on investments on our condensed consolidated statement of operations for thesix months ended June 30, 2023.
Note 5 – Real Estate Owned
Real Estate Owned, Held for Investment
As of June 30, 2024, assets and liabilities related to real estate owned, held for investment consisted ofthree properties: the D.C. Hotel, a full-service luxury hotel in Washington, D.C., the Brooklyn Development, a multifamily development property located in downtown Brooklyn, NY, and the Atlanta Hotel, a hotel in Atlanta, GA.
D.C. Hotel
On May 24, 2021, we acquired legal title to the D.C. hotel, which previously secured two subordinate loans, through a deed-in-lieu of foreclosure. In accordance with ASC 805, we consolidated the hotel's assets and liabilities at their respective fair values. Refer to "Note 3 – Fair Value Disclosure" for full discussion of non-recurring fair value measurements.
As of March 1, 2022, the hotel assets, comprised of land, building, furniture, fixtures, and equipment ("FF&E"), and accumulated depreciation (collectively "REO Fixed Assets"), and liabilities met the criteria to be classified as held for sale under ASC Topic 360, "Property, Plant, and Equipment" ("ASC 360"). Accordingly, as of March 1, 2022, we ceased recording depreciation on the building and FF&E on the condensed consolidated statement of operations.
As of March 1, 2023, due to market conditions, we curtailed active marketing efforts, and reclassified the REO Fixed Assets and liabilities from real estate owned, held for sale to real estate owned, held for investment, net. In accordance with ASC 360, the REO Fixed Assets were reclassified to their carrying value before they were initially classified as held for sale in March of 2022, and all other assets and liabilities were reclassified to the corresponding line items on the condensed consolidated balance sheet. Upon reclassification, we recorded $4.0 million of depreciation expense, representing the amount that would have been recorded had the asset remained as held for investment, and included this amount within Depreciation and amortization on real estate owned on our condensed consolidated statement of operations for the six months ended June 30, 2023. No realized gain or loss was recorded in connection with this reclassification.
As of June 30, 2024 and December 31, 2023, the value of net real estate assets related to the D.C. Hotel was$158.5 million and$152.4 million, respectively. As of June 30, 2024, our net real estate assets included depreciable assets of$79.9 million, net of$7.9 million in accumulated depreciation, attributable to the building, and$5.7 million, net of$4.6 million in accumulated depreciation, attributable to FF&E. As of December 31, 2023, our net real estate assets included depreciable assets of$80.5 million, net of$6.6 million in accumulated depreciation, attributable to the building, and$6.1 million, net of$3.8 million in accumulated depreciation, attributable to FF&E.
During the three months ended June 30, 2024, we obtained a $73.7 million mortgage secured by the D.C. Hotel. The mortgage includes an interest rate of term one-month SOFR +3.00% and current maturity of July 2026, with an option to extend forone year, contingent upon meeting certain conditions. The mortgage agreement contains covenants requiring our unencumbered liquidity be greater than $10.0 million and our net worth be greater than $200.0 million. Under these covenants, our General CECL Allowance is added back to our net worth calculation.
The carrying value of the mortgage included within debt related to real estate owned, held for investment, net on our condensed consolidated balance sheet was$72.3 million, net of$1.4 million in deferred financing costs. To manage our exposure to variable cash flows on our borrowings under this mortgage, we entered into an interest rate cap on June 13, 2024. As of June 30, 2024, the fair value of the interest rate cap was de minimis. Refer to "Note 11 - Derivatives" for full detail.
We recorded net profit from hotel operations of$4.8 million and$5.9 million for three and six months ended June 30, 2024, respectively, and net profit of$5.7 million and$3.8 million for the three and six months ended June 30, 2023, respectively.
Brooklyn Development
In 2015, we originated a $122.2 million multifamily development commercial mortgage loan secured by an assemblage of properties in downtown Brooklyn, NY. In 2020, the loan went into default, and we recorded a $30.0 million Specific CECL Allowance, due to the deterioration of market conditions attributable to COVID-19. As a result of improved market conditions, we reversed $20.0 millionof Specific CECL Allowance during the second quarter of 2021. In the second quarter of 2022, we reversedthe remaining $10.0 million Specific CECL Allowance as a result of market rent growth and value created from development activities at the underlying property.
On August 3, 2022, we acquired legal title of the property through a deed-in-lieu of foreclosure and accounted for the asset acquisition in accordance with ASC 805. At that time, our amortized cost basis in the commercial mortgage loan was $226.5 million. We recorded the real estate assumed at a fair value of $270.1 million based on the market value of the property as of the date of acquisition. We recognized a realized gain of $43.6 million, recorded within realized gain (loss) on investments on our condensed consolidated statement of operations, which reflects the difference between the fair value of the property and the carrying value of the loan at the time of acquisition. The non-recurring fair value measurement was classified as Level III within the fair value hierarchy due to the use of significant unobservable inputs, including comparable sales of similar properties in the market. We capitalized construction and financing costs of$39.9 million and$77.4 million during the three and six months ended June 30, 2024, respectively, and$15.2 million and$29.1 million during the three and six months ended June 30, 2023, respectively. As of June 30, 2024 and December 31, 2023, our cost basis in the property was$451.6 million and$374.2 million, respectively. As of June 30, 2024 and December 31, 2023, our cost basis included construction costs of$230.4 million and$152.9 million, respectively. There is no depreciation recorded while the property is under development.
Upon taking title, we concurrently contributed the property to a joint venture with a third-party real estate developer. The entity was deemed to be a VIE, of which we were determined to be the primary beneficiary. Through our wholly owned subsidiaries, we hold a 100% equity ownership interest in the joint venture and our partner is only entitled to profit upon achievement of certain returns under our joint venture agreement. Concurrently with taking title to the property, we obtained $164.8 million in construction financing on the property. As of June 30, 2024 and December 31, 2023, the carrying value of the construction financing included within debt related to real estate owned, held for investment, net on our condensed consolidated balance sheets was$163.1 million, net of$2.6 million in deferred financing costs and$161.6 million, net of$3.2 million in deferred financing costs, respectively.
The construction financing includes a maximum commitment of $388.4 million, aninterest rate of SOFR +2.55%, and current maturity of August 2026, with an option to extend forone year, contingent upon meeting certain conditions. The construction financing agreement contains covenants requiring our unencumbered liquidity be greater than $100.0 million and our net worth be greater than $600.0 million. Under these covenants, our General CECL Allowance is added back to our net worth calculation. As of both June 30, 2024 and December 31, 2023, we were in compliance with these covenants.
To manage our exposure to variable cash flows on our borrowings under this construction financing, we entered into an interest rate cap on September 26, 2023. As of June 30, 2024 and December 31, 2023, the fair value of the interest rate cap was$0.7 million and$1.4 million, respectively, and recorded within derivative assets, net on our condensed consolidated balance sheet. Refer to "Note 11 - Derivatives" for full detail.
Atlanta Hotel
In March 2017, we originated a first mortgage loan secured by the Atlanta Hotel. During the second quarter of 2022, due to slower than expected recovery from the COVID-19 pandemic, we deemed the borrower to be experiencing financial difficulty. Accordingly, we ceased accruing interest on the loan and recorded a $7.0 million Specific CECL Allowance.
During the fourth quarter of 2022, we wrote off the $7.0 million previously recorded Specific CECL Allowance and reduced the principal balance of the loan which was recorded as a realized loss within net realized loss on investments in our December 31, 2022 consolidated statement of operations.
On March 31, 2023, we acquired legal title of the Atlanta Hotel through a deed-in-lieu of foreclosure and determined the fair value of net real estate assets to be $75.0 million in accordance with ASC 820. The fair value of the real estate owned is categorized within Level III of the fair value hierarchy set forth by ASC 820 and includes the use of significant unobservable inputs. See "Note 3 - Fair Value Disclosure" for discussion of our non-recurring fair value measurements. Additionally, we recognized a realized loss of $4.8 million, recorded within net realized loss on investments on our condensed consolidated statement of operations. The realized loss represents the difference between the original loan's amortized cost and the fair value of the net assets acquired.
During the three months ended June 30, 2023, we received an unsolicited offer from a third party to purchase the Atlanta Hotel. As of June 30, 2023, the hotel's assets and liabilities met the criteria to be classified as held for sale under ASC 360. In accordance with ASC 360, we ceased recording depreciation on the building and FF&E on the condensed consolidated statement of operations and we have reclassified assets and liabilities from their respective condensed consolidated balance sheet line items to Assets related to real estate owned, held for sale and Liabilities related to real estate owned, held for sale.
As of March 31, 2024, we determined the sale of the Atlanta Hotel to a third party, from whom we received an unsolicited offer, to be no longer probable, and we are not actively marketing the property for sale to other potential buyers. As such, the Atlanta Hotel no longer met the criteria to be classified as held for sale under ASC 360. In accordance with ASC 360, the REO Fixed Assets were reclassified to their carrying value before classifying as held for sale in June of 2023. On the date of reclassification, March 31, 2024, we recorded $3.6 million in depreciation, representing the amount that would have been recorded had the asset remained as held for investment. All other assets and liabilities were reclassified to the corresponding line items on the condensed consolidated balance sheet. No realized gain or loss was recorded in connection with this reclassification.
As of June 30, 2024, the value of net real estate assets related to the Atlanta Hotel was$69.9 million. As of June 30, 2024, our net real estate assets included depreciable assets of$46.2 million, net of$3.9 million in accumulated depreciation, attributable to the building, and$6.7 million, net of$2.1 million in accumulated depreciation, attributable to FF&E. For the three and six months ended June 30, 2024, we recorded net profit/(loss) from the hotel's operations of$0.2 million and($1.6) million, respectively. For the three and six months ended June 30, 2023, we recorded$1.4 million of net income from the hotel's operations.
As of December 31, 2023, the hotel's assets and liabilities were classified as held for sale, and the value of net real estate assets related to the Atlanta Hotel was$75.4 million. As of December 31, 2023, our net real estate assets included depreciable assets of$49.4 million, net of$0.8 million in accumulated depreciation, attributable to the building, and$8.0 million, net of$0.4 million in accumulated depreciation, attributable to FF&E.
Note 6 – Other Assets
The following table details the components of our other assets at the dates indicated ($ in thousands):
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| Interest receivable | $74,981 | $72,354 |
| Loan proceeds held by servicer(1) | 5,434 | 6,271 |
| Other(2) | 10,052 | 6,998 |
| Total | $90,467 | $85,623 |
(1)
Includes loan principal and interest held by our third-party servicers as of the balance sheet date and remitted during subsequent remittance cycle.
(2)
Includes$8.4 million and$4.6 million of other assets from Real Estate Owned, Held for Investment as of June 30, 2024 and December 31, 2023, respectively. Refer to "Note 5 – Real Estate Owned" for additional information.
Note 7 – Secured Debt Arrangements, Net
We utilize secured debt arrangements to finance the origination activity in our loan portfolio. Our secured debt arrangements are comprised of secured credit facilities, a private securitization, and a revolving credit facility.
During the six months ended June 30, 2024, we entered into a new secured credit facility with Goldman Sachs. The facility is secured by a first mortgage loan on a European portfolio of pubs and provides £125.6 million ($158.9 million, assuming conversion into USD) of additional borrowing capacity.
Additionally, during the six months ended June 30, 2024, we upsized the Barclays facility by$300.0 million and the Atlas Facility by$113.5 million. The amendment to upsize the Atlas Facility also included conversion of the facility's term from a six month "evergreen" feature to two-years, with a one-year extension option, reduction to recourse percentages, and an additional pledge of a commercial mortgage loan, among other changes. Furthermore, we have repaid the full amount of borrowings outstanding on both the Goldman Sachs USD and Santander EUR facilities.
Our borrowings under secured debt arrangements as of June 30, 2024 and December 31, 2023 are detailed in the following table ($ in thousands):
| June 30, 2024 | December 31, 2023 | |||||
|---|---|---|---|---|---|---|
| MaximumAmount ofBorrowings(1) | BorrowingsOutstanding(1) | Maturity (2) | MaximumAmount ofBorrowings(1) | BorrowingsOutstanding(1) | Maturity (2) | |
| JPMorgan Facility - USD(3)(4) | $1,482,701 | $1,016,233 | September 2026 | $1,482,584 | $1,043,964 | September 2026 |
| JPMorgan Facility - GBP(3)(4) | 17,299 | 17,299 | September 2026 | 17,416 | 17,416 | September 2026 |
| Deutsche Bank Facility - USD(3) | 700,000 | 177,979 | March 2026 | 700,000 | 275,815 | March 2026 |
| Atlas Facility - USD(5) | 800,000 | 756,416 | March 2027(6) | 686,527 | 669,302 | April 2027(7)(8) |
| HSBC Facility - GBP | 381,373 | 381,373 | May 2025 | 383,967 | 383,967 | May 2025 |
| HSBC Facility - EUR | 273,089 | 273,089 | January 2026(8) | 281,401 | 281,401 | January 2026 |
| Goldman Sachs Facility - USD | — | — | N/A(9) | 13,437 | 13,437 | November 2025(9) |
| Goldman Sachs Facility - GBP | 158,863 | 158,863 | January 2029 | — | — | N/A |
| Barclays Facility - USD | 500,000 | 353,153 | March 2027(7) | 200,000 | 107,929 | June 2027(7) |
| MUFG Securities Facility - GBP | 203,308 | 203,308 | August 2025(7) | 204,690 | 204,690 | June 2025(7) |
| Churchill Facility - USD | 130,000 | 123,902 | April 2026 | 130,000 | 126,515 | March 2026 |
| Santander Facility - USD | 300,000 | 67,500 | February 2026(7) | 300,000 | 67,500 | February 2026(7) |
| Santander Facility - EUR(10) | — | — | N/A | 59,611 | 55,716 | August 2024 |
| Total Secured Credit Facilities | 4,946,633 | 3,529,115 | 4,459,633 | 3,247,652 | ||
| Barclays Private Securitization - GBP, EUR, SEK | 2,093,561 | 2,093,561 | July 2026(8) | 2,369,125 | 2,157,157 | June 2026(8) |
| Revolving Credit Facility - USD(11) | 170,000 | 17,000 | March 2026 | 170,000 | 147,000 | March 2026 |
| Total Secured Debt Arrangements | 7,210,194 | 5,639,676 | 6,998,758 | 5,551,809 | ||
| Less: deferred financing costs | N/A | (10,751) | N/A | (13,333) | ||
| Total Secured Debt Arrangements, net(12)(13)(14) | $7,210,194 | $5,628,925 | $6,998,758 | $5,538,476 | ||
(1)
As of June 30, 2024, British Pound Sterling("GBP"), Euro ("EUR"), and Swedish Krona ("SEK") borrowings were converted to USD at a rate of 1.26,1.07, and 0.09, respectively. As of December 31, 2023, GBP, EUR and SEK borrowings were converted to USD at a rate of 1.27,1.10 and 0.10, respectively.
(2)
Maturity date assumes extensions at our option are exercised with consent of financing providers, where applicable.
(3)
The JPMorgan Facility and Deutsche Bank Facility enable us to elect to receive advances in USD, GBP, or EUR.
(4)
The JPMorgan Facility allows for $1.5 billion of maximum borrowings in total as of June 30, 2024.
(5)
The Atlas Facility (as defined below) was formerly the Credit Suisse Facility. See "Atlas Facility" below for additional discussion.
(6)
The Atlas Facility was amended during March 2024 to convert the facility's maturity from asix month "evergreen" feature to atwo-year initial term, with an additionalone-year extension option.
(7)
Assumes financings are extended in line with the underlying loans.
(8)
Represents weighted-average maturity across various financings with the counterparty. See below for additional details.
(9)
Facility entered thetwo-year amortization period during Q4 2023. During the amortization period, the maturity date for current outstanding transactions are extended for a period of up to two years from the November 2023 maturity. The facility was terminated during thethree months ended June 30, 2024, in conjunction with repayment of the underlying loan securing the facility.
(10)
The facility was terminated during the three months ended June 30, 2024 in conjunction with repayment of the underlying loan securing the facility.
(11)
The current stated maturity of the Revolving Credit Facility (as defined below) is March 2026. Borrowings under the Revolving Credit Facility bear interest at a per annum rate equal to the sum of (i) a floating rate index and (ii) a fixed margin. Borrowings under the Revolving Credit Facility are full recourse to certain guarantor wholly-owned subsidiaries of the Company. See "Revolving Credit Facility" below for additional discussion.
(12)
Weighted-average borrowing costs as of June 30, 2024 and December 31, 2023 were applicable benchmark rates and credit spread adjustments, plus spreads of USD: +2.51% / GBP: +2.23% / EUR: +1.89% / SEK: +1.50% and USD: +2.49% / GBP: +2.21% / EUR: +1.86%/ SEK: +1.50%, respectively.
(13)
Weighted-average advance rates based on cost as of June 30, 2024 and December 31, 2023 were 69.1% (63.9% (USD) /73.4% (GBP) /71.3% (EUR) /
80.3% (SEK)) and 68.4% (62.9% (USD) /72.5% (GBP) /72.1% (EUR) /80.4% (SEK)), respectively.
(14)
As of June 30, 2024 and December 31, 2023, approximately 50% and 58%, respectively, is the outstanding balance under these secured borrowings were recourse to us.
Terms of our secured credit facilities are designed to keep each lender's credit exposure generally constant as a percentage of the underlying value of the assets pledged as security to the facility. If the credit of the underlying collateral value decreases, the amount of leverage to us may be reduced. As of June 30, 2024 and December 31, 2023, the weighted-average haircut under our secured debt arrangements was approximately 30.9% and 31.6%, respectively. Our secured credit facilities do not contain capital markets-based mark-to-market provisions.
Atlas Facility
On February 8, 2023, in connection with the acquisition by certain subsidiaries of Atlas, which is a wholly-owned investment of a fund managed by an affiliate of the Manager, the Credit Suisse Facility was acquired by Atlas ("Atlas Facility"). For full discussion of this transaction, refer to "Note 15 - Related Party Transactions."
Revolving Credit Facility
On March 3, 2023, we entered into the revolving credit facility (the "Revolving Credit Facility") administered by Bank of America, N.A. The Revolving Credit Facility provides up to $170.0 million of borrowings secured by qualifying commercial mortgage loans and real property owned assets. The Revolving Credit Facility has a term ofthree years, maturing in March 2026. The Revolving Credit Facility enables us to borrow on qualifying commercial mortgage loans for up totwo years and real property owned assets for up tosix months. As of June 30, 2024 and December 31, 2023, we had$17.0 million and$147.0 million, respectively, outstanding on the Revolving Credit Facility. During the three and six months ended June 30, 2024, we recorded$77.1 thousand and$110.7 thousand in unused fees and$0.4 million and$2.3 million in contractual interest expense, respectively. During the three and six months ended June 30, 2023, we recorded$85.9 thousand and$113.3 thousand in unused fees, respectively.
Barclays Private Securitization
We are party to a private securitization with Barclays Bank plc ("Barclays") (such securitization, the "Barclays Private Securitization"). Commercial mortgage loans currently financed under the Barclays Securitization are denominated in GBP, EUR and SEK.
The Barclays Private Securitization does not include daily margining provisions and grants us significant discretion to modify certain terms of the underlying collateral including waiving certain loan-level covenant breaches and deferring or waiving of debt service payments for up to 18 months. The securitization includes loan-to-value based covenants with deleveraging requirements that are based on significant declines in the value of the collateral as determined by an annual third-party (engaged by us) appraisal process tied to the provisions of the underlying loan agreements. We believe this provides us with both cushion and predictability to avoid sudden unexpected outcomes and material repayment requirements.
The table below provides principal balances and the carrying value for commercial mortgage loans pledged to the Barclays Private Securitization as of June 30, 2024 and December 31, 2023 ($ in thousands):
| Local Currency | Count | OutstandingPrincipal | Carrying Value |
|---|---|---|---|
| GBP | 7 | $1,765,416 | $1,746,563 |
| EUR | 5 | 861,624 | 854,049 |
| SEK | 1 | 234,334 | 232,965 |
| Total | 13 | $2,861,374 | $2,833,577 |
| Local Currency | Count | OutstandingPrincipal | Carrying Value |
|---|---|---|---|
| GBP | 7 | $1,662,457 | $1,643,979 |
| EUR | 6 | 1,021,272 | 1,012,987 |
| SEK | 1 | 248,088 | 246,220 |
| Total | 14 | $2,931,817 | $2,903,186 |
The table below provides the borrowings outstanding (on an as converted basis) and weighted-average fully-extended maturities by currency for the assets financed under the Barclays Private Securitization as of June 30, 2024 ($ in thousands):
| BorrowingsOutstanding(1) | Fully-ExtendedMaturity(2) | |
|---|---|---|
| Total/Weighted-Average GBP | $1,302,697 | July 2026 |
| Total/Weighted-Average EUR | 603,397 | September 2026(3) |
| Total/Weighted-Average SEK | 187,467 | May 2026 |
| Total/Weighted-Average Securitization | $2,093,561 | July 2026 |
(1)
As of June 30, 2024, we had£1.0 billion,€563.2 million, and kr 2.0 billion of borrowings outstanding under the Barclays Private Securitization secured by certain of our commercial mortgage loans.
(2)
Assumes underlying loans extend to fully extended maturity and extensions at our option are exercised.
(3)
The EUR portion of the Barclays Private Securitization has an "evergreen" feature such that the facility continues forone year and can be terminated by either party on certain dates with, depending on the date of notice, a minimum of nine to twelve months' notice.
The table below provides the borrowings outstanding (on an as converted basis) and weighted-average fully-extended maturities by currency for the assets financed under the Barclays Private Securitization as of December 31, 2023 ($ in thousands):
| BorrowingsOutstanding(1) | Fully-ExtendedMaturity(2) | |
|---|---|---|
| Total/Weighted-Average GBP | 1,234,740 | June 2026 |
| Total/Weighted-Average EUR | 723,947 | May 2026(3) |
| Total/Weighted-Average SEK | 198,470 | May 2026 |
| Total/Weighted-Average Securitization | $2,157,157 | June 2026 |
(1)
As of December 31, 2023, we had£969.9 million,€655.8 million, and kr$2.0 billion of borrowings outstanding under the Barclays Private Securitization secured by certain of our commercial mortgage loans.
(2)
Assumes underlying loans extend to fully extended maturity and extensions at our option are exercised.
(3)
The EUR portion of the Barclays Private Securitization has an "evergreen" feature such that the facility continues forone year and can be terminated by either party on certain dates with, depending on the date of notice, a minimum of nine to twelve months' notice.
The table below provides the assets and liabilities of the Barclays Private Securitization VIE included in our condensed consolidated balance sheets ($ in thousands):
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| Assets: | ||
| Cash | $251 | $924 |
| Commercial mortgage loans, net(1) | 2,833,577 | 2,903,186 |
| Other Assets | 41,074 | 41,180 |
| Total Assets | $2,874,902 | $2,945,290 |
| Liabilities: | ||
| Secured debt arrangements, net (net of deferred financing costs of $1.6 million and $2.0 million in 2024 and 2023, respectively) | $2,091,979 | $2,155,197 |
| Accounts payable, accrued expenses and other liabilities(2) | 9,174 | 9,083 |
| Total Liabilities | $2,101,153 | $2,164,280 |
(1)
Net of the General CECL Allowance of$12.3 million and$8.3 million as of June 30, 2024 and December 31, 2023, respectively.
(2)
Includes General CECL Allowance related to unfunded commitments on commercial mortgage loans, net of$2.6 million and$2.5 million as of June 30, 2024 and December 31, 2023, respectively.
The table below provides the net income of the Barclays Private Securitization VIE included in our condensed consolidated statement of operations ($ in thousands):
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Net interest income: | ||||
| Interest income from commercial mortgage loans | $63,596 | $52,781 | $128,119 | $99,758 |
| Interest expense | (36,019) | (27,241) | (72,102) | (50,374) |
| Net interest income | $27,577 | $25,540 | $56,017 | $49,384 |
| General and administrative expense | $(2) | $(7) | $(2) | $(7) |
| Decrease (increase) in current expected credit loss allowance, net | (1,574) | (774) | (4,139) | (575) |
| Foreign currency translation gain (loss) | (487) | 10,709 | (13,410) | 20,711 |
| Net income | $25,514 | $35,468 | $38,466 | $69,513 |
At June 30, 2024, our borrowings had the following remaining maturities ($ in thousands):
| Less than 1 year | 1 to 3 years | 3 to 5 years | More than 5 years | Total | |
|---|---|---|---|---|---|
| JPMorgan Facility | $27,299 | $1,006,233 | $— | $— | $1,033,532 |
| Deutsche Bank Facility | — | 177,979 | — | — | 177,979 |
| Atlas Facility | — | 756,416 | — | — | 756,416 |
| HSBC Facility | 500,938 | 153,524 | — | — | 654,462 |
| Goldman Sachs Facility - GBP | — | — | 158,863 | — | 158,863 |
| Barclays Facility | — | 353,153 | — | — | 353,153 |
| MUFG Securities Facility | 203,308 | — | — | — | 203,308 |
| Churchill Facility | — | 123,902 | — | — | 123,902 |
| Santander Facility - USD | 67,500 | — | — | — | 67,500 |
| Barclays Private Securitization | 446,764 | 1,451,855 | 194,942 | — | 2,093,561 |
| Revolving Credit Facility | — | 17,000 | — | — | 17,000 |
| Total | $1,245,809 | $4,040,062 | $353,805 | $— | $5,639,676 |
The table above reflects the fully extended maturity date of the facility and assumes facilities with an "evergreen" feature continue to extend through the fully-extended maturity of the underlying asset and assumes underlying loans are extended with consent of financing providers.
The table below summarizes the outstanding balances at June 30, 2024, as well as the maximum and average month-end balances for the six months ended June 30, 2024 for our borrowings under secured debt arrangements ($ in thousands).
| As of June 30, 2024 · For the six months ended June 30, 2024 | ||||
|---|---|---|---|---|
| Balance | Collateral(1) | MaximumMonth-EndBalance | AverageMonth-EndBalance | |
| JPMorgan Facility | $1,033,532 | 1,832,152 | 1,063,261 | $1,050,021 |
| Deutsche Bank Facility | 177,979 | 283,753 | 278,703 | 229,539 |
| Goldman Sachs Facility - USD | — | — | 11,620 | 5,806 |
| Goldman Sachs Facility - GBP | 158,863 | 210,043 | 160,082 | 158,750 |
| Atlas Facility | 756,416 | 1,106,774 | 758,201 | 716,764 |
| HSBC Facility | 654,462 | 852,491 | 660,827 | 655,723 |
| Barclays Facility | 353,153 | 458,646 | 353,153 | 142,967 |
| MUFG Securities Facility | 203,308 | 276,781 | 204,867 | 203,163 |
| Churchill Facility | 123,902 | 164,987 | 126,080 | 124,991 |
| Santander Facility - USD | 67,500 | 99,824 | 67,500 | 67,500 |
| Santander Facility - EUR | — | — | 54,677 | 45,368 |
| Barclays Private Securitization | 2,093,561 | 2,845,877 | 2,146,965 | 2,082,679 |
| Revolving Credit Facility | 17,000 | 27,089 | 150,000 | 66,167 |
| Total | $5,639,676 | $8,158,417 | ||
(1)
Represents the amortized cost balance of commercial loan collateral assets and the value of net real estate assets of real property owned collateral assets.
The table below summarizes the outstanding balances at December 31, 2023, as well as the maximum and average month-end balances for the year ended December 31, 2023 for our borrowings under secured debt arrangements ($ in thousands).
| As of December 31, 2023 · For the year ended December 31, 2023 | ||||
|---|---|---|---|---|
| Balance | Collateral(1) | MaximumMonth-EndBalance | AverageMonth-EndBalance | |
| JPMorgan Facility | $1,061,380 | $1,871,854 | $1,324,226 | $1,190,651 |
| Deutsche Bank Facility | 275,815 | 419,170 | 385,818 | 322,676 |
| Goldman Sachs Facility | 13,437 | 28,533 | 70,249 | 30,482 |
| Atlas Facility | 669,302 | 933,085 | 688,126 | 667,794 |
| HSBC Facility | 665,368 | 860,134 | 667,430 | 651,758 |
| Barclays Facility | 107,929 | 129,439 | 111,909 | 110,729 |
| MUFG Securities Facility | 204,690 | 278,223 | 206,362 | 200,447 |
| Churchill Facility | 126,515 | 168,138 | 130,000 | 128,094 |
| Santander Facility - USD | 67,500 | 99,648 | 75,000 | 68,125 |
| Santander Facility - EUR | 55,716 | 74,288 | 55,716 | 54,347 |
| Barclays Private Securitization | 2,157,157 | 2,911,470 | 2,157,157 | 1,896,144 |
| Revolving Credit Facility | 147,000 | 319,048 | 147,000 | 93,500 |
| Total | $5,551,809 | $8,093,030 | ||
(1)
Represents the amortized cost balance of commercial loan collateral assets and the value of net real estate assets of real property owned collateral assets.
Debt Covenants
The guarantees related to our secured debt arrangements contain the following financial covenants: (i) tangible net worth must be greater than $1.25 billion plus 75% of the net cash proceeds of any equity issuance after March 31, 2017; (ii) our ratio of total indebtedness to tangible net worth cannot be greater than 3.75:1 (ratio is 4.00:1 for the Revolving Credit Facility); and (iii) our liquidity cannot be less than an amount equal to the greater of 5% of total recourse indebtedness or $30.0 million. Under these covenants, our General CECL Allowance is added back to our tangible net worth calculation. The Revolving Credit Facility contains an additional financial covenant to maintain a minimum interest coverage ratio of 1.4:1. During October 2023, we modified our interest coverage ratio covenant related to the Revolving Credit Facility to a minimum of 1.4:1 from a minimum of 1.5:1.
We were in compliance with the covenants under each of our secured debt arrangements at June 30, 2024 and December 31, 2023. The impact of macroeconomic conditions on the commercial real estate markets and global capital markets, including increased interest rates, foreign currency fluctuations, changes to fiscal and monetary policy, slower economic growth or recession, labor shortages, and recent distress in the banking sector, may make it more difficult to meet or satisfy these covenants in the future.
Note 8 – Senior Secured Term Loans, Net
In May 2019, we entered into a $500.0 million senior secured term loan (the "2026 Term Loan"), which matures in May 2026 and contains restrictions relating to liens, asset sales, indebtedness, and investments in non-wholly owned entities. The 2026 Term Loan was issued at a price of 99.5%. During the second quarter of 2023, the 2026 Term Loan transitioned from LIBOR to SOFR and currently bears interest at SOFR plus 2.86%.
In March 2021, we entered into an additional $300.0 million senior secured term loan, with substantially the same terms as the 2026 Term Loan, (the "2028 Term Loan" and, together with the 2026 Term Loan, the "Term Loans") which matures in March 2028 and contains restrictions relating to liens, asset sales, indebtedness, and investments in non-wholly owned entities. The 2028 Term Loan was issued at a price of 99.0%. During the second quarter of 2023, the 2028 Term Loan transitioned from LIBOR to SOFR and currently bears interest at SOFR (with a floor of 0.50%) plus 3.61%.
The Term Loans are amortizing with repayments of 0.25% per quarter of the total committed principal. During thethree and six months ended June 30, 2024 and 2023, we repaid$1.3 million and$2.5 million of principal, respectively, related to the 2026 Term Loan. During the three and six months ended June 30, 2024 and 2023, we repaid$750 thousand and$1.5 million of principal respectively related to the 2028 Term Loan.
The following table summarizes the terms of the Term Loans as of June 30, 2024 ($ in thousands):
| Principal Amount | Unamortized Issuance Discount(1) | Deferred Financing Costs(1) | Carrying Value | Rate | Maturity Date | |
|---|---|---|---|---|---|---|
| 2026 Term Loan | $475,000 | $(655) | $(3,545) | $470,800 | 2.86% | 5/15/2026 |
| 2028 Term Loan | 290,250 | (1,571) | (2,806) | 285,873 | 3.61% | 3/11/2028 |
| Total | $765,250 | $(2,226) | $(6,351) | $756,673 | ||
(1)
Unamortized issuance discount and deferred financing costs will be amortized to interest expense over remaining life of respective term loans.
The following table summarizes the terms of the Term Loans as of December 31, 2023 ($ in thousands):
| Principal Amount | Unamortized Issuance Discount(1) | Deferred Financing Costs(1) | Carrying Value | Rate | Maturity Date | |
|---|---|---|---|---|---|---|
| 2026 Term Loan | $477,500 | $(833) | $(4,302) | $472,365 | 2.86% | 5/15/2026 |
| 2028 Term Loan | 291,750 | (1,786) | (3,179) | 286,785 | 3.61% | 3/11/2028 |
| Total | $769,250 | $(2,619) | $(7,481) | $759,150 | ||
(1)
Unamortized issuance discount and deferred financing costs will be amortized to interest expense over remaining life of respective term loans.
Covenants
The financial covenants of the Term Loans include the requirements that we maintain: (i) a maximum ratio of total recourse debt to tangible net worth of 4:1; and (ii) a ratio of total unencumbered assets to total pari-passu indebtedness of at least 2.50:1. We were in compliance with the covenants under the Term Loans at June 30, 2024 and December 31, 2023.
Interest Rate Cap
In June 2020, we entered into an interest rate cap to manage our exposure to variable cash flows on our borrowings under our 2026 senior secured term loan by effectively limiting LIBOR from exceeding 0.75%. This limited the maximum all-in coupon on our 2026 senior secured term loan to 3.50%.
Subsequent to the interest rate cap maturity on June 15, 2023, the effective all-in coupon on our 2026 Term Loan increased to one month SOFR plus the spread of 2.86%. Refer to "Note 11 – Derivatives" for further detail.
Note 9 – Senior Secured Notes, Net
In June 2021, we issued $500.0 million of 4.625% Senior Secured Notes due 2029 (the "2029 Notes"), for which we received net proceeds of $495.0 million, after deducting initial purchasers' discounts and commissions. The 2029 Notes will mature on June 15, 2029, unless earlier repurchased or redeemed. The 2029 Notes are secured by a first-priority lien, and rank pari-passu in right of payment with all of our existing and future first lien obligations, including indebtedness under the Term Loans. The 2029 Notes were issued at par and contain covenants relating to liens, indebtedness, and investments in non-wholly owned entities. The 2029 Notes had a carrying value of$496.0 million and$495.6 million, net of deferred financing costs of$4.0 million and$4.4 million, as of June 30, 2024 and December 31, 2023, respectively.
Covenants
The 2029 Notes include certain covenants including a requirement that we maintain a ratio of total unencumbered assets to total pari-passu indebtedness of at least 1.20:1. As of June 30, 2024 and December 31, 2023, we were in compliance with all covenants.
Note 10 – Convertible Senior Notes, Net
During the fourth quarter of 2018, we issued $230.0 million of the 5.375% Convertible Senior Notes due 2023 (the "2023 Notes" or "Convertible Notes"), for which we received $223.7 million after deducting the underwriting discount and offering expenses.
During the three and six months ended June 30, 2023, we repurchased $36.8 million and $43.9 million of aggregate principal amount of the 2023 Notes at a weighted-average price of 99.3% and 98.9%, respectively. As a result of this transaction, we recorded a gain of $0.3 million and $0.5 million within gain on extinguishment of debt in our condensed consolidated statement of operations for the three and six months ended June 30, 2023, respectively. The gain represents the difference between the repurchase price and the carrying amount of the 2023 Notes, net of the proportionate amount of unamortized debt issuance costs. During the third quarter of 2023, we repurchased an additional $10.0 million of aggregate principal amount of the 2023 Notes at a weighted-average price of 99.7%. During the fourth quarter of 2023, we repaid the remaining $176.1 million outstanding principal of the 2023 Notes in cash at par. All repurchase transactions occurred in the open market as a result of reverse inquiries from investors with no solicitation from us.
The aggregate contractual interest expense was approximately $2.8 million and $5.8 million for thethree and six months ended June 30, 2023. With respect to the amortization of the discount on the liability component of the Convertible Notes as well as the amortization of deferred financing costs, we reported additional non-cash interest expense of approximately $0.4 million and $0.8 million for thethree and six months ended June 30, 2023.
Note 11 – Derivatives
We use forward currency contracts to economically hedge interest and principal payments due under our loans denominated in currencies other than USD.
We have entered into a series of forward contracts to sell an amount of foreign currency (GBP, EUR and SEK) for an agreed upon amount of USD at various dates through February 2027. These forward contracts were executed to economically fix the USD amounts of foreign denominated cash flows expected to be received by us related to foreign denominated loan investments.
The agreements with our derivative counterparties require that we post collateral to secure net liability positions. As of both June 30, 2024 and December 31, 2023, we were in a net asset position with all of our derivative counterparties and did not have any collateral posted under these derivative contracts.
The following table summarizes our non-designated Fx forwards and interest rate cap as of June 30, 2024:
| Type of Derivatives | Number ofContracts | AggregateNotional Amount(in thousands) | NotionalCurrency | Maturity | Weighted-AverageYears to Maturity |
|---|---|---|---|---|---|
| Fx contracts - GBP | 85 | 963,399 | GBP | July 2024 - February 2027 | 1.00 |
| Fx contracts - EUR | 114 | 481,209 | EUR | July 2024 - August 2026 | 0.69 |
| Fx contracts - SEK | 16 | 663,828 | SEK | August 2024 - May 2026 | 1.75 |
| Interest rate cap | 2 | 238,535 | USD | October 2024 - July 2025 | 0.49 |
The following table summarizes our non-designated Fx forwards and interest rate cap as of December 31, 2023:
| Type of Derivatives | Number ofContracts | AggregateNotional Amount(in thousands) | NotionalCurrency | Maturity | Weighted-AverageYears to Maturity |
|---|---|---|---|---|---|
| Fx contracts - GBP | 97 | 938,903 | GBP | January 2024 - February 2027 | 1.13 |
| Fx contracts - EUR | 135 | 561,441 | EUR | January 2024 - August 2026 | 1.08 |
| Fx contracts - SEK | 17 | 690,740 | SEK | February 2024 - May 2026 | 2.16 |
| Interest rate cap | 1 | 164,835 | USD | October 2024 | 0.75 |
We have not designated any of our derivative instruments as hedges as defined in ASC 815, "Derivatives and Hedging" and, therefore, changes in the fair value of our derivative instruments are recorded directly in earnings. The following table summarizes the amounts recognized on our condensed consolidated statements of operations related to our forward currency contracts for thethree and six months ended June 30, 2024 and 2023 ($ in thousands):
| Amount of gain (loss) recognized in income · Amount of gain (loss) recognized in income | |||||
|---|---|---|---|---|---|
| Three Months Ended June 30, · Six Months Ended June 30, | |||||
| Location of Gain (Loss) Recognized in Income | 2024 | 2023 | 2024 | 2023 | |
| Forward currency contracts | Unrealized gain (loss) on derivative instruments | $911 | $(20,102) | $18,964 | $(55,953) |
| Forward currency contracts | Realized gain (loss) on derivative instruments | 5,466 | 2,986 | 10,811 | 24,702 |
| Total | $6,377 | $(17,116) | $29,775 | $(31,251) | |
In June 2020, we entered into an interest rate cap for approximately $1.1 million, which matured on June 15, 2023. Our interest rate cap managed our exposure to variable cash flows on our borrowings under the senior secured term loan by effectively limiting LIBOR from exceeding 0.75%. This limited the maximum all-in coupon on our senior secured term loan to 3.50%. The unrealized gain or loss related to the interest rate cap was recorded net under unrealized gain on interest rate hedging instruments in our condensed consolidated statement of operations. During thethree and six months ended June 30, 2023, LIBOR exceeded the cap rate of 0.75%. As such, during thethree and six months ended June 30, 2023, we realized a gain from the interest rate cap in the amount of$4.4 million and$9.1 million, respectively, which is included in gain (loss) on interest rate hedging instruments in our condensed consolidated statement of operations. The realized gain was a result of the increase in the current interest rate forward curve, partially offset by the nearing maturity of the cap.
On September 26, 2023, we entered into an interest rate cap that matures on October 1, 2024 with a notional amount of $164.8 million. We use our interest rate cap to hedge our exposure to variable cash flows on our construction financing. The interest rate cap effectively limits SOFR from exceeding 4.00% which results in the maximum all-in coupon on our construction financing of 6.55%. The unrealized gain or loss related to the interest rate cap was recorded under gain (loss) on interest rate hedging instruments in our condensed consolidated statement of operations. During thethree and six months ended June 30, 2024, SOFR exceeded the cap rate of 4.00%. As such, during thethree and six months ended June 30, 2024, we realized a gain from the interest rate cap in the amount of$0.6 million and$1.1 million, respectively, which is included in gain (loss) on interest rate hedging instruments in our condensed consolidated statement of operations.
On June 13, 2024, we entered into an interest rate cap that matures on July 1, 2025 with a notional amount of $73.7 million. We use our interest rate cap to hedge our exposure to variable cash flows on our floating rate mortgage related to the D.C. Hotel. The interest rate cap effectively limits SOFR from exceeding 6.00% which results in the maximum all-in coupon on mortgage of 9.00%. The unrealized gain or loss related to the interest rate cap was recorded under gain (loss) on interest rate hedging instruments in our condensed consolidated statement of operations. During the three months ended June 30, 2024, SOFR did not exceed the cap rate of 6.00%, and accordingly, no realized gain was recorded.
The following table summarizes the amounts recognized on our condensed consolidated statements of operations related to our interest rate caps for thethree and six months ended June 30, 2024 and 2023 ($ in thousands):
| Amount of gain (loss) recognized in income · Amount of gain (loss) recognized in income | |||||
|---|---|---|---|---|---|
| Three Months Ended June 30, · Six Months Ended June 30, | |||||
| Location of Gain (Loss) recognized in Income | 2024 | 2023 | 2024 | 2023 | |
| Interest rate caps | Unrealized gain (loss) on interest rate hedging instruments | $(457) | $(4,328) | $(651) | $(9,141) |
| Interest rate caps | Realized gain on interest rate hedging instruments | 551 | 4,383 | 1,101 | 9,089 |
| Total | $94 | $55 | $450 | $(52) | |
The following tables summarize the gross asset and liability amounts related to our derivatives at June 30, 2024 and December 31, 2023 ($ in thousands):
| June 30, 2024 · December 31, 2023 | ||||||
|---|---|---|---|---|---|---|
| GrossAmount ofRecognizedAssets | GrossAmountsOffset in ourCondensedConsolidatedBalance Sheet | Net Amountsof Assets Presented inour CondensedConsolidatedBalance Sheet | GrossAmount ofRecognizedAssets | GrossAmountsOffset in our ConsolidatedBalance Sheet | Net Amountsof AssetsPresentedin ourConsolidatedBalance Sheet | |
| Forward currency contracts | $67,325 | $(20,296) | $47,029 | $55,102 | $(27,037) | $28,065 |
| Interest rate caps | 720 | — | 720 | 1,360 | — | 1,360 |
| Total derivative assets (liabilities) | $68,045 | $(20,296) | $47,749 | $56,462 | $(27,037) | $29,425 |
Note 12 – Participations Sold
Participations sold represented the subordinate interests in loans we originated and subsequently partially sold. We account for participations sold as secured borrowings on our condensed consolidated balance sheet with both assets and non-recourse liabilities because the participations do not qualify as a sale under ASC 860. The income earned on the participations sold is recorded as interest income and an identical amount is recorded as interest expense in our condensed consolidated statements of operations.
In December 2020, we sold a £6.7 million ($8.9 million assuming conversion into USD at time of transfer) interest, at par, in a first mortgage loan collateralized by an office building located in London, United Kingdom that was originated by us in December 2017. In connection with this sale, we transferred our remaining unfunded commitment of £19.1 million ($25.3 million assuming conversion into USD at time of transfer). The participation interest sold was subordinate to our first mortgage loan and was accounted for as a secured borrowing on our consolidated balance sheet. In January 2023, the first mortgage loan, including participations sold, was fully satisfied, including all contractual and default interest accrued to date. We had no participations sold as of June 30, 2024 or December 31, 2023.
Note 13 – Accounts Payable, Accrued Expenses and Other Liabilities
The following table details the components of our accounts payable, accrued expense and other liabilities ($ in thousands):
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| Collateral held under derivative agreements | $51,610 | $25,820 |
| Accrued dividends payable | 51,894 | 53,407 |
| Accrued interest payable | 31,983 | 31,012 |
| Accounts payable and other liabilities(1) | 10,004 | 6,078 |
| General CECL Allowance on unfunded commitments(2) | 3,622 | 4,017 |
| Total | $149,113 | $120,334 |
(1)
Includes$9.4 million and$5.5 million of accounts payable and other liabilities on the balance sheet of the Real Estate Owned, Held for Investment at June 30, 2024 and December 31, 2023, respectively.
(2)
Refer to "Note 4 - Commercial Mortgage Loans, Subordinate Loans and Other Lending Assets, Net" for additional disclosure related to the General CECL Allowance on unfunded commitments as of June 30, 2024 and December 31, 2023, respectively.
Note 14 – Income Taxes
We have elected to be taxed as a REIT under the Internal Revenue Code of 1986, as amended, commencing with the taxable year ended December 31, 2009. As a REIT, U.S. federal income tax law generally requires us to distribute annually at least 90% of our REIT taxable income, without regard to the deduction for dividends paid and excluding net capital gains, and that we pay tax at regular corporate rates to the extent that we annually distribute less than 100% of our net taxable income. We are also subject to U.S. federal, state and local income taxes on our domestic taxable REIT subsidiaries ("TRS") based on the tax jurisdictions in which they operate.
During the three and six months ended June 30, 2024, we recorded a current income tax provision of$0.1 million and$0.2 million, respectively, related to activities of our taxable REIT subsidiaries. We didnot record any income tax provision during thethree and six months ended June 30, 2023.
There was a $0.4 million and $0.6 million income tax asset related to the operating activities of our TRS entities as of June 30, 2024 and December 31, 2023, respectively. As of June 30, 2024 and December 31, 2023, there were no material deferred tax assets or liabilities.
As of June 30, 2024, we had net operating losses of $13.7 million and capital losses of $25.2 million that may be carried forward for use in subsequent periods.
As of June 30, 2024, tax years 2019 through 2023 remain subject to examination by taxing authorities.
Note 15 – Related Party Transactions
Management Agreement
In connection with our initial public offering in September 2009, we entered into a management agreement (the "Management Agreement") with the Manager, which describes the services to be provided by the Manager and its compensation for those services. The Manager is responsible for managing our day-to-day operations, subject to the direction and oversight of our board of directors.
Pursuant to the terms of the Management Agreement, the Manager is paid a base management fee equal to 1.5% per annum of our stockholders' equity (as defined in the Management Agreement), calculated and payable (in cash) quarterly in arrears.
The term of the Management Agreement was automatically renewed for a successiveone-year term on September 29, 2023 and will automatically renew on each anniversary thereafter. The Management Agreement may be terminated upon expiration of theone-year extension term only upon the affirmative vote of at least two-thirds of our independent directors, based upon (1) unsatisfactory performance by the Manager that is materially detrimental to ARI or (2) a determination that the management fee payable to the Manager is not fair, subject to the Manager's right to prevent such a termination based on unfair fees by accepting a mutually acceptable reduction of management fees agreed to by at least two-thirds of our independent directors. The Manager must be provided with written notice of any such termination at least 180 days prior to the expiration of the then existing term and will be paid a termination fee equal tothree times the sum of the average annual base management fee during the 24-month period immediately preceding the date of termination, calculated as of the end of the most recently completed fiscal quarter prior to the date of termination. Following a meeting of our independent directors in March 2024, which included a discussion of the Manager's performance and the level of the management fees thereunder, we determined not to seek termination of the Management Agreement.
We incurred approximately$9.2 million and$18.6 million in base management fees under the Management Agreement for the three and six months ended June 30, 2024, respectively, as compared to$9.4 million and$18.9 million for the three and six months ended June 30, 2023, respectively.
In addition to the base management fee, we are also responsible for reimbursing the Manager for certain expenses paid by the Manager on our behalf or for certain services provided by the Manager to us. For the three and six months ended June 30, 2024 we paid expenses totaling$2.0 million and$3.8 million, respectively, related to reimbursements for certain expenses paid by the Manager on our behalf under the Management Agreement as compared to$1.4 million and$2.6 million for three and six months ended June 30, 2023, respectively. Expenses incurred by the Manager and reimbursed by us are reflected in the respective condensed consolidated statement of operations expense category or our condensed consolidated balance sheets based on the nature of the item.
Included in payable to related party on our condensed consolidated balance sheets at June 30, 2024 and December 31, 2023 is approximately$9.2 million and$9.6 million, respectively, for base management fees incurred but not yet paid under the Management Agreement.
Loans receivable
During the first quarter of 2023, we transferred interests in, (i)three commercial mortgage loans secured by various properties in Europe, with aggregate commitments of €205.7 million (of which €115.0 million was funded at the time of sale), and (ii) a partial interest of £15.0 million in a commercial mortgage loan secured by a mixed-use property located in London, United Kingdom. These transfers were made to entities managed by affiliates of the Manager. Refer to "Note 4 – Commercial Mortgage Loans, Subordinate Loans and Other Lending Assets, Net" for additional disclosure.
Term Loan
In March 2021, Apollo Global Funding, LLC, an affiliate of the Manager, served as one of the eight arrangers for the issuance of our 2028 Term Loan and received $0.2 million of arrangement fees. In addition, funds managed by an affiliate of the Manager invested in $30.0 million of the 2028 Term Loan.
Senior Secured Notes
In June 2021, Apollo Global Securities, LLC, an affiliate of the Manager, served as one of the eight initial purchasers in the issuance of our 2029 Notes and received $0.4 million of initial purchasers' discounts and commissions.
Italian Direct Lending Structure
In the fourth quarter of 2021, we formed an Italian closed-end alternative investment fund (the "AIF"), managed by Apollo Investment Management Europe (Luxembourg) S.A R.L, a regulated alternative investment fund manager (the "AIFM"), an affiliate of the Manager. The management fees incurred during the three and six months ended June 30, 2024 and 2023, respectively were de minimis. As of June 30, 2024 and December 31, 2023, the fees payable to the AIFM were de minimis.
Atlas Facility
On February 8, 2023, in connection with the acquisition by certain subsidiaries of Atlas, which is a wholly-owned investment of a fund managed by an affiliate of the Manager, the Credit Suisse Facility was acquired by Atlas. In order to effect the assignment of the Credit Suisse Facility and related agreements, the Company and one of its subsidiaries, similar to the other sellers and guarantors party to the subject agreements in the transaction, entered into an Omnibus Assignment, Assumption and Amendment Agreement as well as certain related agreements with Credit Suisse AG and Atlas. At the time of acquisition, we had $632.3 million of secured debt on the Credit Suisse Facility consisting of four commercial mortgage loans.
As of June 30, 2024 and December 31, 2023, respectively, we had$756.4 million and$669.3 million of secured debt on the Atlas Facility consisting offive andfour commercial mortgage loans. Refer to "Note 7 – Secured Debt Arrangements, Net" for additional discussion.
Note 16 – Share-Based Payments
On June 17, 2024, our board of directors adopted the Apollo Commercial Real Estate Finance, Inc. 2024 Equity Incentive Plan ("2024 LTIP"). Following the approval of the 2024 LTIP by our stockholders at our 2024 annual meeting of stockholders on June 7, 2024, no additional awards have been or will be granted under the Apollo Commercial Real Estate Finance, Inc. 2019 Equity Incentive Plan ("2019 LTIP," and together with the 2024 LTIP, the "LTIPs" or "Equity Incentive Plans") and all outstanding awards granted under the 2019 LTIP remain in effect in accordance with the terms in the 2019 LTIP.
The 2024 LTIP provides for grants of restricted common stock, restricted stock units ("RSUs") and other equity-based awards up to an aggregate of 7,500,000 shares of our common stock. The LTIPs are administered by the compensation committee of our board of directors (the "Compensation Committee") and all grants under the LTIPs must be approved by the Compensation Committee.
We recognized stock-based compensation expense related to restricted stock and RSU vesting of$4.2 million and$8.3 million during the three and six months ended June 30, 2024, respectively, and$4.4 million and$8.7 million during the three and six months ended June 30, 2023, respectively.
The following table summarizes the grants, vesting and forfeitures of restricted common stock and RSUs during thesix months ended June 30, 2024:
| Type | Restricted Stock | RSUs | Grant Date Fair Value ($ in millions) |
|---|---|---|---|
| Outstanding at December 31, 2023 | 79,088 | 2,538,332 | |
| Granted | 63,980 | — | 0.7 |
| Vested | (75,754) | (37,548) | N/A |
| Forfeiture | — | (21,112) | N/A |
| Outstanding at June 30, 2024 | 67,314 | 2,479,672 |
Below is a summary of restricted stock and RSU vesting dates as of June 30, 2024:
| Vesting Year | Restricted Stock | RSUs | Total Awards |
|---|---|---|---|
| 2024 | 3,334 | 1,264,867 | 1,268,201 |
| 2025 | 63,980 | 857,826 | 921,806 |
| 2026 | — | 356,979 | 356,979 |
| Total | 67,314 | 2,479,672 | 2,546,986 |
At June 30, 2024, we had unrecognized compensation expense of approximately$0.5 million and$22.2 million related to the vesting of restricted stock awards and RSUs, respectively, noted in the table above. The unrecognized compensation expense related to the vesting of restricted awards and RSUs are expected to be recognized over a weighted-average period of 1.4 years.
RSU Deliveries
During the six months ended June 30, 2024 and 2023, we delivered 739,620 and 671,428 shares of common stock for 1,360,779 and 1,236,071 vested RSUs, respectively. We allow RSU participants to settle their tax liabilities with a reduction of their share delivery from the originally granted and vested RSUs. The amount, when agreed to by the participant, results in a cash payment to the Manager related to this tax liability and a corresponding adjustment to additional paid in capital on our condensed consolidated statement of changes in stockholders' equity. The adjustment was$7.3 million and$6.7 million for the six months ended June 30, 2024 and 2023, respectively. The adjustment is a reduction of capital related to our equity incentive plan and is presented net of increases of capital related to our equity incentive plan in our condensed consolidated statement of changes in stockholders' equity.
Note 17 – Stockholders' Equity
Our authorized capital stock consists of 450,000,000 shares of common stock, $0.01 par value per share and 50,000,000 shares of preferred stock, $0.01 par value per share. As of June 30, 2024,138,438,433 shares of common stock were issued and outstanding and 6,770,393 shares of our 7.25% Series B-1 Cumulative Redeemable Perpetual Preferred Stock ("Series B-1 Preferred Stock") were issued and outstanding. The Series B-1 Preferred Stock, with a par value $0.01 per share, have a liquidation preference of $25.00 per share.
Dividends. The following table details our dividend activity:
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| Dividends declared per share of: | 2024 | 2023 | 2024 | 2023 |
| Common Stock | $0.35 | $0.35 | $0.70 | $0.70 |
| Series B-1 Preferred Stock | $0.45 | $0.45 | $0.90 | $0.90 |
Common Stock Repurchases. During the three and six months ended June 30, 2024, we repurchased 3,723,772 shares of our common stock at a weighted-average price of$10.16 per share. As of June 30, 2024, the approximate dollar value of shares that may yet be purchased under our stock repurchase program was$134.5 million.
Note 18 – Commitments and Contingencies
Legal Proceedings. From time to time, we may be involved in various claims and legal actions arising in the ordinary course of business. On June 28, 2018, AmBase Corporation, 111 West 57th Street Manager Funding LLC and 111 West 57th Investment LLC commenced a now-dismissed action captioned AmBase Corporation et al v. ACREFI Mortgage Lending, LLC et al (No 653251/2018) in New York Supreme Court (the "Apollo Action"). The complaint named as defendants (i) a wholly-owned subsidiary of the Company (the "Subsidiary"), (ii) the Company, and (iii) certain funds managed by Apollo, who were co-lenders on a mezzanine loan against the development of a residential condominium building in Manhattan, New York. The plaintiffs alleged that the defendants tortiously interfered with the plaintiffs' joint venture agreement with the developers of the project, and that the defendants aided and abetted breaches of fiduciary duty by the developers of the project. The plaintiffs alleged the loss of a $70.0 million investment plus punitive damages. The defendants' motion to dismiss was granted on October 23, 2019 and the Court entered judgment dismissing the complaint in its entirety on November 8, 2019. Plaintiffs appealed, the parties fully briefed the appeal, and then Plaintiffs dropped the appeal, and the case remains dismissed.
Plaintiffs amended the complaint in a separate action in 2021, 111 West 57th Investment LLC v. 111W57 Mezz Investor LLC (No. 655031/2017) also in New York Supreme Court (the "April 2021 Action") to name Apollo Global Management, Inc., the Subsidiary, the Company, and certain funds managed by Apollo as defendants. The April 2021 Action concerns overlapping claims and the same condominium development project that the Apollo Action concerned. The defendants filed a motion to dismiss, which was granted in part and denied in part on December 15, 2022. The Court dismissed the claim against Apollo Global Management, Inc. and the Company. Apollo appealed the decision with respect to the remaining claim. On October 5, 2023, the Appellate Division, First Department granted Apollo's appeal, thereby dismissing the remaining claim against the Apollo entities who were co-lenders on the mezzanine loan, including the Subsidiary. Plaintiffs filed a motion for leave with the Court of Appeals on November 3, 2023 which the Court denied on April 23, 2024. On July 12, 2024, Plaintiffs filed new motions for leave to appeal to the Court of Appeals, despite the earlier ruling. No reasonable estimate of possible loss, if any, can be made at this time. The Company believes the new motions are without merit.
Loan Commitments. As described in "Note 4 - Commercial Mortgage Loans, Subordinate Loans and Other Lending Assets, Net" at June 30, 2024, we had$436.6 million of unfunded commitments related to our commercial mortgage and subordinate loans. The timings and amounts of fundings are uncertain as these commitments relate to loans for construction costs, capital expenditures, leasing costs, interest and carry costs, among others. As such, the timings and amounts of future fundings depend on the progress and performance of the underlying assets of our loans. Certain of our lenders are contractually obligated to fund their ratable portion of these loan commitments over time, while other lenders have some degree of discretion over future loan funding obligations. The total unfunded commitment is expected to be funded over the remaining 2.6 years weighted-average tenor of these loans.
Note 19 – Fair Value of Financial Instruments
The following table presents the carrying value and estimated fair value of our financial instruments not carried at fair value on our condensed consolidated balance sheets at June 30, 2024 and December 31, 2023 ($ in thousands):
| June 30, 2024 | December 31, 2023 | |||
|---|---|---|---|---|
| CarryingValue | EstimatedFair Value | CarryingValue | EstimatedFair Value | |
| Cash and cash equivalents | $174,703 | $174,703 | $225,438 | $225,438 |
| Commercial mortgage loans, net | 7,909,125 | 7,791,941 | 7,925,359 | 7,813,304 |
| Subordinate loans, net | 384,777 | 384,777 | 432,734 | 432,458 |
| Secured debt arrangements, net | (5,628,925) | (5,628,925) | (5,538,476) | (5,538,476) |
| Senior secured term loans, net | (756,673) | (747,834) | (759,150) | (754,197) |
| Senior secured notes, net | (496,033) | (419,375) | (495,637) | (418,750) |
| Debt related to real estate owned, held for investment, net | (235,418) | (235,418) | (161,586) | (161,586) |
To determine estimated fair values of the financial instruments listed above, market rates of interest, which include credit assumptions, are used to discount contractual cash flows. The estimated fair values are not necessarily indicative of the amount we could realize on disposition of the financial instruments. The use of different market assumptions or estimation methodologies could have a material effect on the estimated fair value amounts. Estimates of fair value for cash and cash equivalents, convertible senior notes, net, and Term Loans, net are measured using observable Level I inputs as defined in "Note 3 - Fair Value Disclosure." Estimates of fair value for all other financial instruments in the table above are measured using significant estimates, or unobservable Level III inputs as defined in "Note 3 - Fair Value Disclosure."
Note 20 – Net Income (Loss) per Share
ASC Topic 260, "Earnings Per Share" requires the use of the two-class method of computing both basic and diluted earnings (loss) per share for all periods presented for each class of common stock and participating securities. Under the two-class method, all earnings (distributed and undistributed) are allocated to common shares and participating securities according to their respective rights to receive dividends. The unvested RSUs granted under our Equity Incentive Plans to certain employees of the Manager qualify as participating securities as RSUs have non-forfeitable rights to participate in dividends. Therefore, unvested RSUs are included in the calculation of basic earnings per share.
Dilutive earnings per share is calculated under the more dilutive computation of the treasury stock method and the if-converted method. Under the treasury stock method, the denominator includes the weighted-average outstanding common shares plus the incremental shares related to participating securities. The incremental shares are determined by subtracting the average unrecognized compensation cost for the period divided by the average stock price from the unvested RSUs.
The table below presents the computation of basic and diluted net income (loss) per share of common stock for thethree and six months ended June 30, 2024 and 2023 ($ in thousands except per share data):
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| Basic Earnings | 2024 | 2023 | 2024 | 2023 |
| Net income (loss) | $35,785 | $(83,400) | $(68,739) | $(34,484) |
| Less: Preferred dividends | (3,068) | (3,068) | (6,136) | (6,136) |
| Less: Earnings attributable to participating securities | — | — | — | — |
| Less: Dividends on participating securities | (880) | (997) | (1,766) | (2,000) |
| Basic Earnings (Loss) | $31,837 | $(87,465) | $(76,641) | $(42,620) |
| Dilutive Earnings | ||||
| Basic Earnings (Loss) | $31,837 | $(87,465) | $(76,641) | $(42,620) |
| Add: Dividends on participating securities | — | — | — | — |
| Diluted Earnings (Loss) | $31,837 | $(87,465) | $(76,641) | $(42,620) |
| Number of Shares: | ||||
| Basic weighted-average shares of common stock outstanding | 140,438,676 | 141,341,238 | 141,154,140 | 141,207,597 |
| Diluted weighted-average shares of common stock outstanding | 140,611,532 | 141,341,238 | 141,154,140 | 141,207,597 |
| Earnings (Loss) Per Share Attributable to Common Stockholders | ||||
| Basic | $0.23 | $(0.62) | $(0.54) | $(0.30) |
| Diluted | $0.23 | $(0.62) | $(0.54) | $(0.30) |
For the three months ended June 30, 2024,172,857 incremental shares were included in the calculation of diluted net income per share because the effect was dilutive. For the six months ended June 30, 2024,283,433 incremental shares were excluded in the calculation of diluted net income per share because the effect was anti-dilutive.
For the three and six months ended June 30, 2023,10,485,087 and 10,835,571, respectively, weighted-average potentially issuable shares with respect to the Convertible Notes were excluded in the dilutive earnings per share denominator because the effect was anti-dilutive.
For the three and six months ended June 30, 2023,2,849,286 and 3,034,394 weighted-average unvested RSUs were excluded in the calculation of diluted net income per share because the effect was anti-dilutive.
Note 21 – Subsequent Events
Subsequent to the quarter ended June 30, 2024, the following events took place:
Investment Activity:
Originated two first mortgage loans, consisting of a £117.5 million ($149.6 assuming conversion into USD) commitment to a floating-rate commercial mortgage loan secured by a portfolio of luxury senior care homes across Greater London, United Kingdom and a £150.4 million ($191.9 million assuming conversion into USD) floating-rate commercial mortgage loan secured by a portfolio of senior care homes throughout the United Kingdom in connection with a refinance.
Funded approximately$49.6 million for previously closed loans.
Loan Repayments: We received approximately$463.6 million from loan repayments, including $421.0 million of full repayments across three first mortgage loans and one subordinate loan.
Share Repurchases: We repurchased 157,424 shares of our common stock at a weighted-average price of$9.92 per share. As of the date of this quarterly report, the approximate dollar value of shares that may yet to be purchased under our stock repurchase program was $132.9 million.
Massachusetts Healthcare: In March 2022, we and other Apollo-managed entities co-originated a 55% loan-to-cost first mortgage loan secured by eight hospitals in Massachusetts. At origination, our portion of the loan totaled $378.7 million. The loan was made in connection with the capitalization of a joint venture between two parties to own the hospitals. That joint venture - through its subsidiaries, which were the mortgage borrowers under the loan – then leased the properties to Steward Health Care ("Steward"), who served as the operator. We and other Apollo-managed entities did not lend to Steward and do not have any involvement in Steward's operation of the hospitals or performance under the lease. The structure and covenants in the loan have provided for cash collateral and amortization since origination that represents approximately 11% of the original loan balance, and our amortized cost basis was $341.9 million as of June 30, 2024. As of the date of this quarterly report, the loan remains current on all contractual interest payments.
Steward filed for Chapter 11 bankruptcy in May 2024. During the three months ended June 30, 2024, we downgraded the loan's risk rating from a three to a four. Subsequent to the date of these condensed consolidated financial statements but prior to the date of this quarterly report, bids for the hospitals were received and the bid process and negotiations are continuing to evolve with multiple constituencies. While there still is a high degree of uncertainty, based upon the information available as of the date of this quarterly report, and taking into account Steward's bankruptcy court documents made publicly available on July 30, 2024, we anticipate recording a Specific CECL Allowance in a subsequent quarter, which we currently estimate to be approximately $90 million. The actual Specific CECL Allowance may differ materially based on continuing developments from the date of this quarterly report.
Item 2. Management's Discussion
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.